US20070106378A1 - Intraocular lens for inhibiting cell growth and reducing glare - Google Patents

Intraocular lens for inhibiting cell growth and reducing glare Download PDF

Info

Publication number
US20070106378A1
US20070106378A1 US11/552,429 US55242906A US2007106378A1 US 20070106378 A1 US20070106378 A1 US 20070106378A1 US 55242906 A US55242906 A US 55242906A US 2007106378 A1 US2007106378 A1 US 2007106378A1
Authority
US
United States
Prior art keywords
optic
peripheral
edge
peripheral edge
anterior
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US11/552,429
Inventor
Marlene Paul
Daniel Brady
Jim Deacon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Johnson and Johnson Surgical Vision Inc
Original Assignee
Advanced Medical Optics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/086,882 external-priority patent/US6162249A/en
Application filed by Advanced Medical Optics Inc filed Critical Advanced Medical Optics Inc
Priority to US11/552,429 priority Critical patent/US20070106378A1/en
Publication of US20070106378A1 publication Critical patent/US20070106378A1/en
Assigned to BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT reassignment BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT INTELLECTUAL PROPERTY SECURITY AGREEMENT Assignors: ADVANCED MEDICAL OPTICS, INC.
Assigned to ADVANCED MEDICAL OPTICS, INC. reassignment ADVANCED MEDICAL OPTICS, INC. RELEASE BY SECURED PARTY (SEE DOCUMENT FOR DETAILS). Assignors: BANK OF AMERICA, N.A. AS ADMINISTRATIVE AGENT
Assigned to Abbott Medical Optics Inc. reassignment Abbott Medical Optics Inc. MERGER (SEE DOCUMENT FOR DETAILS). Assignors: ADVANCED MEDICAL OPTICS, INC.
Priority to US14/181,146 priority patent/US9949822B2/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/14Eye parts, e.g. lenses, corneal implants; Implanting instruments specially adapted therefor; Artificial eyes
    • A61F2/16Intraocular lenses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/14Eye parts, e.g. lenses, corneal implants; Implanting instruments specially adapted therefor; Artificial eyes
    • A61F2/16Intraocular lenses
    • A61F2/1613Intraocular lenses having special lens configurations, e.g. multipart lenses; having particular optical properties, e.g. pseudo-accommodative lenses, lenses having aberration corrections, diffractive lenses, lenses for variably absorbing electromagnetic radiation, lenses having variable focus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/14Eye parts, e.g. lenses, corneal implants; Implanting instruments specially adapted therefor; Artificial eyes
    • A61F2/16Intraocular lenses
    • A61F2/1613Intraocular lenses having special lens configurations, e.g. multipart lenses; having particular optical properties, e.g. pseudo-accommodative lenses, lenses having aberration corrections, diffractive lenses, lenses for variably absorbing electromagnetic radiation, lenses having variable focus
    • A61F2/1659Intraocular lenses having special lens configurations, e.g. multipart lenses; having particular optical properties, e.g. pseudo-accommodative lenses, lenses having aberration corrections, diffractive lenses, lenses for variably absorbing electromagnetic radiation, lenses having variable focus having variable absorption coefficient for electromagnetic radiation, e.g. photochromic lenses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/0077Special surfaces of prostheses, e.g. for improving ingrowth
    • A61F2002/009Special surfaces of prostheses, e.g. for improving ingrowth for hindering or preventing attachment of biological tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/0077Special surfaces of prostheses, e.g. for improving ingrowth
    • A61F2002/009Special surfaces of prostheses, e.g. for improving ingrowth for hindering or preventing attachment of biological tissue
    • A61F2002/0091Having cellular growth inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/14Eye parts, e.g. lenses, corneal implants; Implanting instruments specially adapted therefor; Artificial eyes
    • A61F2/16Intraocular lenses
    • A61F2002/1681Intraocular lenses having supporting structure for lens, e.g. haptics
    • A61F2002/16901Supporting structure conforms to shape of capsular bag
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/14Eye parts, e.g. lenses, corneal implants; Implanting instruments specially adapted therefor; Artificial eyes
    • A61F2/16Intraocular lenses
    • A61F2002/1696Having structure for blocking or reducing amount of light transmitted, e.g. glare reduction
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/14Eye parts, e.g. lenses, corneal implants; Implanting instruments specially adapted therefor; Artificial eyes
    • A61F2/16Intraocular lenses
    • A61F2002/16965Lens includes ultraviolet absorber
    • A61F2002/1699Additional features not otherwise provided for

Definitions

  • This invention relates to intraocular lenses (IOLs) and, more particularly, to IOLs which inhibit migration or growth of cells from the eye onto the IOL and reduce glare in the eye.
  • IOLs intraocular lenses
  • An intraocular lens is commonly used to replace the natural lens of a human eye when warranted by medical conditions. It is common practice to implant an IOL in a region of the eye known as the capsular bag or posterior capsule.
  • a common treatment for this condition is to use a laser to destroy the cells and a central region of the capsular bag. Although this treatment is effective, the laser is expensive and is not available throughout the world. There is also cost associated with the laser treatment as well as some patient inconvenience and risk of complications. Finally, the laser treatment may affect the performance of some IOLs.
  • Another potential concern after certain IOLs are implanted has to do with glare caused by light reflecting off of the IOLs, in particular, the edges of IOLs. Such glare can be an annoyance to the patient and may even lead to removal and replacement of the IOL.
  • IOLs which inhibit growth of cells from the eye onto the IOLs and/or which reduce glare caused by the IOLs in the eye.
  • IOLs are effective to inhibit cell growth, in particular epithelial cell growth, from the eye onto the optic of the IOLs.
  • the IOLs are structured so as to reduce glare, in particular edge glare, in the eye resulting from the presence of the IOL.
  • the present IOLs are straightforward in design and construction, are easily manufactured, can be implanted, or inserted in the eye using conventional techniques, and are effective and produce substantial benefits in use in the eye.
  • the present IOLs are implantable in the eye and comprise an optic having a central optical axis, an anterior face, an opposing posterior face and a peripheral edge or edge surface between the faces.
  • the optic is adapted for placement in the capsular bag of the eye and for directing light toward the retina of the eye.
  • the IOLs further comprise at least one fixation member, preferably two fixation members, and more preferably two elongated fixation members, coupled to the optic for use in fixing the IOLs in the eye.
  • the present invention provides a reduced-glare intraocular lens implantable in the eye and including an optic adapted for placement in the capsular bag of the eye for directing light toward the retina of the eye.
  • the optic has a central optical axis, an anterior face, an opposing posterior face, and a peripheral edge.
  • the peripheral edge has a least one surface with a linear cross-sectional configuration that is oriented other than parallel to the central optical axis. Further, the peripheral edge and the anterior face, and/or the peripheral edge and the posterior face, intersect to form at least one peripheral edge corner located at a discontinuity between the peripheral edge and the intersecting anterior or posterior face.
  • the peripheral edge may also include a rounded transition surface on its anterior side, wherein the peripheral edge corner is provided only between the peripheral edge and intersecting posterior face.
  • the peripheral edge may also include two linear surfaces angled with respect to one another, wherein the other linear surface may be oriented parallel to the optical axis.
  • a reduced-glare intraocular lens implantable in an eye comprises an optic adapted for placement in the capsular bag of the eye and for directing light toward the retina of the eye.
  • the optic has a central optical axis, an anterior face, and a posterior face.
  • An outer edge of the optic is defined by a peripheral edge that includes, in cross-section, a linear surface that is non-parallel with respect to the optical axis and a posterior corner defining the posterior limit of the peripheral edge.
  • cell growth from the eye in front of or in back of the optic is more inhibited relative to a substantially identical intraocular lens without the posterior corner, and reduced glare is obtained in the eye relative to a substantially identical intraocular lens having a peripheral linear surface that is parallel to the central optical axis.
  • the optic may also include a convex surface on the peripheral edge defining a transition surface between the anterior face and the linear surface.
  • a second linear surface that is parallel with respect to the optical axis may also be provided.
  • the optic may include first and second linear surfaces, wherein the first linear surface is anteriorly-facing and second linear surface is parallel with respect to the optical axis.
  • an intraocular lens implantable in an eye includes an optic adapted for placement in the capsular bag of the eye and for directing light toward the retina of the eye.
  • the optic includes a peripheral edge extending between an anterior face and a posterior face consisting only of a conical surface.
  • the conical surface may be posteriorly-facing, wherein the conical surface is sufficiently angled with respect to the optical axis so as to increase transmission of light from the optic through the conical surface relative to a substantially identical intraocular lens with a peripheral edge consisting only of a surface parallel to the optical axis.
  • a peripheral land extends between the anterior face and conical surface, wherein the conical surface is generally posteriorly-facing and wherein the conical surface and the peripheral land adjacent the conical surface define an acute included angle.
  • the conical surface may be anteriorly-facing, wherein the conical surface is sufficiently angled with respect to the optical axis so as to decrease the probability of light internal to the optic contacting the conical surface relative to a substantially identical intraocular lens with a peripheral edge consisting only of a surface parallel to the optical axis.
  • an intraocular lens including an optic defining a central optical axis, an anterior face, and a posterior face.
  • a peripheral edge extending between the anterior face and the posterior face includes, in cross-section, a linear edge surface terminating at its anterior side in an anterior edge corner.
  • the present invention provides an intraocular lens having optic defining optical axis, an anterior face, and a posterior face.
  • a peripheral edge stands between the anterior face and posterior face and includes, in cross-section, at least two linear edge surfaces that are not parallel to the optical axis.
  • the two linear edge surfaces may be angled radially inwardly toward each other to meet an apex and together define a groove. Further, a plurality of such grooves may be provided by adjoining linear edge surfaces.
  • a rounded transition surface extending between an anteriorly-facing edge surface and the anterior face of the optic may also be provided.
  • the peripheral edge of the present IOLs may have a substantially continuous curved configuration in the direction between the anterior and posterior faces of the optic, that is between the faces in a cross-sectional plane including the optical axis. Indeed, the entire peripheral edge may have a substantially continuous curved configuration in the direction between the anterior and posterior faces of the optic.
  • the peripheral edge of the present IOLs may have a curved surface, a flat surface that is either parallel to the optical axis or not, or a combination of flat and/or curved surfaces.
  • a portion of the peripheral edge has a substantially continuous curved configuration
  • another portion, for example, the remaining portion, of the peripheral edge preferably has a linear configuration in the direction between the anterior and posterior faces of the optic which is not parallel to the optical axis.
  • the present IOLs preferably provide reduced glare in the eye relative to the glare obtained with a substantially identical IOL having a peripheral edge parallel (flat) to the central optical axis in the direction between the faces of the optic.
  • a substantially identical IOL having a peripheral edge parallel (flat) to the central optical axis in the direction between the faces of the optic.
  • One or more of at least part of the peripheral edge, a portion of the anterior face near the peripheral edge and a portion of the portion face near the peripheral edge may be at least partially opaque to the transmission of light, which opacity is effective in reducing glare.
  • Such opacity can be achieved in any suitable manner, for example, by providing “frosting” or physically or chemically roughening selected portions of the optic.
  • peripheral corner which may be considered a sharp, abrupt or angled peripheral corner, is effective in inhibiting migration or growth of cells from the eye onto the IOL.
  • the present IOLs with one or two such angled peripheral corners, provide that cell growth from the eye in front of or in back of the optic is more inhibited relative to a substantially identical IOL without the sharp, abrupt or angled peripheral corner or corners.
  • peripheral edge and the intersecting face or faces intersect at an angle or angles, preferably in a range of about 45° to about 135°, more preferably in a range of about 60° to about 120°.
  • an obtuse angle that is greater than 90° and less than 180°. Such angles of intersection are very effective in facilitating the inhibition of cell migration or growth onto and/or over the anterior face and/or posterior face of the optic of the present IOL.
  • At least one, conceivably both, of the anterior face and the posterior face has a peripheral region extending from the peripheral edge toward the central optical axis.
  • the peripheral region or regions preferably are substantially planar, and may or may not be substantially perpendicular to the central optical axis.
  • only the anterior face has a peripheral region extending from the peripheral edge toward the central optical axis which is substantially planar, more preferably substantially perpendicular to the central optical axis.
  • the peripheral region preferably has a radial dimension of at least about 0.1 mm, and more preferably no greater than about 2 mm.
  • the dimension of the optic parallel to the central optical axis between the anterior face and the posterior face preferably is smaller at or near the peripheral edge, for example, at the peripheral region or regions, than at the central optical axis.
  • At least a part or a portion of the peripheral edge surface of the optic is generally convex relative to the central optical axis.
  • at least a part or a portion of the peripheral edge surface of the optic is generally concave relative to the central optical axis.
  • a first portion of the peripheral edge surface is generally convex relative to the central optical axis and a second portion of the peripheral edge surface is generally concave relative to the optical axis.
  • the peripheral edge and/or the peripheral region or regions circumscribe the central optical axis.
  • the anterior face and the posterior face preferably are both generally circular in configuration, although other configurations, such as oval, elliptical and the like, may be employed.
  • At least one of the anterior and posterior faces has an additional region, located radially inwardly of the peripheral region, which is other than substantially planar.
  • FIG. 1 is a plan view of one form of intraocular lens (IOL) constructed in accordance with the teachings of present invention.
  • IOL intraocular lens
  • FIG. 2 is a cross-sectional view of an optic of a prior art IOL.
  • FIG. 3 is an elevational view of an optic of an exemplary embodiment of an IOL of the present invention having a medium diopter value.
  • FIG. 4 is an elevational view of an optic of a further exemplary IOL of the present invention having a small diopter value.
  • FIG. 5 is an elevational view of an optic of a further exemplary IOL of the present invention having a large diopter value.
  • FIG. 6 is an elevational view of a peripheral edge region of the IOL of FIG. 3 showing the paths of a plurality of light rays passing therethrough.
  • FIG. 7 is a cross-sectional view of a peripheral edge region of an IOL of the present invention having an edge surface that is parallel to the optical axis, an anteriorly-facing edge surface that is not parallel to the optical axis and an anterior peripheral land that is perpendicular to the optical axis.
  • FIG. 8 is a cross-sectional view of a peripheral edge region of an IOL of the present invention having an anteriorly-facing edge surface not parallel to the optical axis and an anterior peripheral land perpendicular to the optical axis.
  • FIG. 9 is a cross-sectional view of a peripheral edge region of an IOL of the present invention having an anteriorly-facing edge surface that is not parallel to the optical axis and no peripheral land.
  • FIG. 10 is a cross-sectional view of a peripheral edge region of an IOL of the present invention having an edge surface that is parallel to the optical axis and an anterior peripheral land that is not perpendicular to the optical axis.
  • FIG. 11 is a cross-sectional view of a peripheral edge region of an IOL of the present invention having an edge surface that is parallel to the optical axis, an anterior peripheral land that is perpendicular to the optical axis, and an anterior peripheral land that is not perpendicular to the optical axis.
  • FIG. 12 is a cross-sectional view of a peripheral edge region of an IOL of the present invention having a posteriorly-facing edge surface that is not parallel to the optical axis and no peripheral land.
  • FIG. 13 is a cross-sectional view of a peripheral edge region of an IOL of the present invention having a posteriorly-facing edge surface that is not parallel to the optical axis and an anterior peripheral land that is perpendicular to the optical axis.
  • FIG. 14 a is a radial sectional view of an IOL of the present invention showing a fixation member extending from a peripheral edge.
  • FIG. 14 b is an elevational view of a peripheral edge region of the IOL of FIG. 14 a.
  • FIGS. 15-17 are elevational views of peripheral edge regions of IOLs of the present invention each having an anteriorly-facing edge surface that is not parallel to the optical axis, a rounded transition surface between the edge surface and the anterior face of the IOL, and a posterior peripheral land.
  • FIG. 18 is an elevational view of a peripheral edge region of an IOL of the present invention having a baffle structure disposed along an anteriorly-facing edge surface.
  • FIG. 19 is an elevational view of a peripheral edge region of an IOL of the present invention having an anteriorly-facing edge surface and a rounded transition surface between the edge surface and the anterior face of the IOL.
  • FIG. 20 is an elevational view of a peripheral edge region of an IOL of the present invention having both anteriorly- and posteriorly-facing edge surfaces.
  • FIG. 21 is a cross-sectional view of the optic of an alternative IOL of the present invention.
  • FIG. 22 is a cross-sectional view of the optic of an alternate embodiment of an IOL in accordance with the present invention.
  • FIG. 23 is a partial cross-sectional view of the optic of a further embodiment of an IOL in accordance with the present invention.
  • FIG. 24 is a partial cross-sectional view of an additional embodiment of an IOL in accordance with the present invention.
  • FIG. 25 is a partial cross-sectional view of the optic of another embodiment of an IOL in accordance with the present invention.
  • FIG. 26 is a partial cross-sectional view of the optic of a further alternate embodiment of an IOL in accordance with the present invention.
  • FIG. 27 is a partial cross-sectional view of the optic of a still further embodiment of an IOL in accordance with the present invention.
  • FIG. 28 is a partial cross-sectional view of the optic of still another embodiment of an IOL in accordance with the present invention.
  • FIG. 1 shows an IOL 20 which generally comprises an optic 22 and fixation members 24 a and 24 b .
  • the optic 22 may be considered as effective for focusing light on or near the retina of the eye.
  • Optical axis 26 passes through the center of optic 22 in a direction generally transverse to the plane of the optic.
  • the optic 22 is circular in plan and bi-convex approaching the optical axis 26 .
  • the optic 22 may be constructed of any of the commonly employed materials used for rigid optics, such as polymethylmethacrylate (PMMA), or commonly employed materials used for resiliently deformable optics, such as silicone polymeric materials, acrylic polymeric materials, hydrogel-forming polymeric materials, mixtures thereof and the like.
  • PMMA polymethylmethacrylate
  • silicone polymeric materials acrylic polymeric materials
  • hydrogel-forming polymeric materials mixtures thereof and the like.
  • fixation members 24 a and 24 b in this embodiment are generally C-shaped and are integral with the optic 22 .
  • the IOLs of the present invention may consist of one piece, with unitary optic and fixation members, or may be three or more pieces, with two or more fixation members connected to the optic.
  • IOL 20 can be produced using conventional techniques well-known in the art.
  • IOL 20 Unless expressly described hereinafter, the general structural characteristics of IOL 20 apply to the other IOLs noted herein.
  • FIG. 2 illustrates an optic 30 of an IOL of the prior art having an optical axis OA, a convex anterior face AF, a convex posterior face PF, and a peripheral edge 32 .
  • the peripheral edge 32 is typically circular and has a constant cross-section circumscribing the optic 30 .
  • the optic 30 illustrated is of the square-cornered variety which provides some inhibition of cell growth onto the optic 30 , a condition known as posterior capsule opacification (PCO).
  • PCO posterior capsule opacification
  • the peripheral edge 32 comprises an edge surface 34 that is parallel to the optical axis OA, and both anterior and posterior edge corners 36 a , 36 b , respectively.
  • anterior and posterior lands 38 a , 38 b extend between the anterior face AF and posterior face PF and respective edge corner 36 a or 36 b . Both the anterior and posterior lands 38 a , 38 b extend substantially perpendicularly with respect to the optical axis OA. Because of the parallel edge surface 34 , the prior art optic 30 does not provide reduced edge glare as do the IOLs in accordance with the present invention.
  • anterior and posterior are used in their conventional sense; anterior refers to the front side of the eye, while posterior refers to the rear side.
  • a number of surfaces of the intraocular lens of present invention are denoted either “anteriorly-facing” or “posteriorly-facing” to indicate their orientation with respect to the optical axis of the lens.
  • a surface that is parallel to the optical axis is neither anteriorly-facing or posteriorly-facing.
  • a surface that is even slightly angled in one direction or the other can be identified with either the anterior or posterior side of the lens, depending on which side that surface faces.
  • FIG. 3 illustrates an optic 40 of an IOL of the present invention having an advantageous peripheral edge 42 .
  • the optic 40 defines an optical axis OA, a convex anterior face AF, and a convex posterior face PF.
  • the peripheral edge 42 is desirably circular in shape, and has a constant cross-section circumscribing the optic 40 .
  • the peripheral edge 42 may not extend completely around the optic 40 , and may be interrupted by alternative peripheral edge configurations, including combinations of peripheral edge configurations in accordance with the present invention.
  • the optic 40 is shown in elevational view to better illustrate the peripheral edge 42 in relation to the convex anterior face AF and posterior face PF.
  • the peripheral edge 42 includes a curved or rounded transition surface 44 leading to an anterior peripheral land or region 46 that is desirably linear and substantially perpendicular to the optical axis OA.
  • a discontinuous posterior edge corner 50 separates the peripheral edge 42 from the posterior face PF, with no peripheral land. The edge corner 50 defines the posterior limit of the peripheral edge 42 .
  • the peripheral edge 42 further comprises an edge surface 52 that is linear and substantially parallel to the optical axis OA adjacent the posterior edge corner 50 , and an anteriorly-facing edge surface 54 that is linear and non-parallel to the optical axis OA adjacent the rounded transition surface 44 .
  • a shallow corner or discontinuity 56 separates the parallel edge surface 52 from the non-parallel edge surface 54 .
  • discontinuity refers to a transition between two peripheral edge surfaces that is visible as a corner or peripheral line on the optic.
  • all corners ultimately have a radius, but discontinuity in this regard pertains only to a corner that is visible as a discrete line as opposed to a more rounded region.
  • “visible” in this regard refers to visible as seen by the naked eye, or with the assistance of certain low-power magnification devices, such as an ocular.
  • Another way to define corners in the presence sense is the intersection between two linear surfaces, at least with respect to the magnification shown in the drawings of the present application.
  • Still another way to look at the effect of a discontinuity at the corner of the peripheral edge is that cell growth from the eye in front of or in back of the optic is more inhibited relative to a substantially identical intraocular lens without the discontinuity.
  • the term “linear,” used to refer to various edge surfaces, is in all cases as viewed through the cross-section of the particular edge. That is, the lenses of the present invention are generally circular, and the peripheral edges thus defined circular surfaces of revolution.
  • a linear cross-sectional edge can therefore defined a cylinder, or a conical surface. If the edge is parallel to the optical axis, the surface is cylindrical. On the other hand, if the surface is non-parallel with respect to the optical axis, the surface is conical. Therefore, a linear, non-parallel edge surface is conical, at least for a portion of the peripheral edge.
  • edge geometry around the periphery of any particular lens of the present invention may not be constant, and the edge surfaces disclosed herein should not be construed as necessarily extending in a constant configuration around the entire periphery of the lens.
  • the anterior peripheral land or region 46 is shown as being linear and substantially perpendicular to the optical axis OA, other configurations are contemplated.
  • the peripheral land 46 could be other than linear, i.e., convex or concave with respect to a plane through the medial plane of the optic.
  • the peripheral land 46 could be angled toward or away from the anterior side.
  • there may be more than one surface defining the peripheral land 46 such as a curved and a linear surface.
  • FIGS. 4 and 5 illustrate two further optics 60 a and 60 b that have substantially the same configuration as the optic 40 of FIG. 3 . That is, both optics 60 a and 60 b have an optical axis OA, a convex anterior face AF, a convex posterior face PF, and a peripheral edge 62 a , 62 b , respectively.
  • Each peripheral edge 62 a , 62 b comprises, respectively, a rounded transition surface 64 a , 64 b , and anterior peripheral land 66 a , 66 b that is substantially perpendicular to the optical axis OA, a posterior edge corner 70 a , 70 b , an edge surface 72 a , 72 b that is substantially parallel to the optical axis OA, and an anteriorly-facing edge surface 74 a , 74 b that is non-parallel to the optical axis OA.
  • FIGS. 3, 4 and 5 illustrate optics of similar configuration that have different dimensions based on their different magnitude of optical correction, or diopter value.
  • the optic 40 of FIG. 3 has an intermediate correction diopter value of 20
  • the optic 60 a of FIG. 4 has a diopter value of 10
  • the optic 60 b of FIG. 5 has a diopter value of 30.
  • These relative diopter values are reflected in the relative convexity of each. That is, the smallest diopter value optic 40 shown in FIG. 4 has relatively shallow convex anterior face AF and posterior face PF.
  • the larger diopter value optic 60 b in FIG. 5 has a larger convexity for both the anterior face AF and posterior face PF.
  • FIGS. 4 and 5 Various dimensions for the respective peripheral edges of the exemplary optics shown in FIGS. 3-5 are also given in FIGS. 4 and 5 . That is, the thickness of each peripheral edge is given as t, the thickness of the parallel edge surface is given as A, the angle of the non-parallel edge surface is given as ⁇ , and a radius of curvature of the transition surface is given as R.
  • the following tables provide exemplary values for these dimensions for the optics 60 a and 60 b of FIGS. 4 and 5 . These dimensions are considered suitable for optics 60 a and 60 b that are made from silicone. It should be noted that the dimensions for the optic 40 of FIG. 3 are desirably approximately equal to those for the optic 60 b of FIG. 5 . It should also be noted that the following dimensions are believed to provide certain benefits as far as reducing glare and PCO in IOLs, although not all the dimensions have been selected for either of those particular purposes. For example, some of the dimensions may be desirable to facilitate manufacturing of the respective IOL.
  • Table I provides exemplary values for optics that are made from acrylic.
  • TABLE I EXEMPLARY DIMENSIONS FOR SILICONS IOLs T 1 (in) t 2 (in) A 1 (in) A 2 (in) ⁇ 1 ⁇ 2 R 1 (in) R 2 (in) .023- .012- .002- .002- 13- 13- .001- .004- .027 .014 .007 .007 17° 17° .003 .006
  • Table II provides exemplary values for the same dimensions as shown in FIGS. 4-5 , but for optics that are made from acrylic.
  • the subscript “1” pertains to optics having a diopter value of 10
  • the subscript “2” pertains to optics having a diopter value of either 20 or 30.
  • the convexity of the various lenses along the optical axis OA increases with increasing diopter value (the posterior face and especially the anterior face are more highly convex).
  • some surgeons prefer the intraocular lenses to have approximately the same volume or center thickness at the optical axis regardless of diopter power. This permits the surgeon to use the same surgical technique across the diopter range. Therefore, the present invention contemplates varying the overall diameter of the optic for different diopter values. That is, the center thickness of the intraocular lenses for different diopter values remains the same regardless of diameter. Therefore, the diameter of lenses having greater convexity should be reduced to reduce the center thickness, and the diameter of flatter lenses should be increased, both to an intermediate value.
  • the diameter of the lower diopter value optic 60 a shown in FIG. 4 may be increased so that the center thickness is closer to the intermediate diopter value optic 40 shown in FIG. 3 .
  • the diameter of the higher diopter value optic 60 b shown in FIG. 5 may be decreased so that the center thickness is closer to the optic 40 shown in FIG. 3 .
  • the present invention contemplates a set of intraocular lenses having varying diopter values wherein the diameter of the optics varies generally inversely (although not necessarily linearly) with respect to the diopter value.
  • a set of intraocular lenses having approximately the same center thickness can be provided to the surgeon to help make the implantation procedure more consistent and predictable.
  • One example of a set of intraocular lenses may include the optics shown in FIGS. 3-5 .
  • the lower diopter lens 60 a of FIG. 4 may have a diameter of approximately 6.25 mm
  • the intermediate diopter lens 40 of FIG. 3 may have a diameter of 6.0 mm
  • the higher diopter lens 60 b of FIG. 5 may have a diameter of 5.75 mm.
  • an increased diameter for lower diopter lenses corresponds to human physiology. That is, people who require lower diopter lenses typically have larger eyes, while people requiring high diopters tend to have smaller eyes.
  • FIG. 6 illustrates a section of the peripheral edge 42 of the optic 40 of FIG. 3 with a plurality of discrete light rays 80 a , 80 b , 80 c , entering the peripheral edge from the anterior side.
  • the refracted/reflected path of each light ray through the peripheral edge 42 is indicated, with the path of each light ray as it exits the peripheral edge 42 indicated as 82 a , 82 b and 82 c.
  • FIG. 6 thus illustrates the advantageous characteristic of the peripheral edge 42 in diffusing incoming parallel light rays so that the reflected light intensity is reduced. That is, any light that ordinarily would reflect back towards the optical axis at near its original intensity is instead diffused to reduce glare in the IOL.
  • the present invention contemplates utilizing a curved or rounded transition surface, such as the surface 44 , in combination with one or more planar edge surfaces that are not parallel to the optical axis, such as the edge surface 54 .
  • the peripheral edge 42 further includes the edge surface 52 that is substantially parallel to the optical axis. It is believed that the combination of the rounded transition surface 44 on the anterior side leading to the anteriorly-facing edge surface 54 substantially reduces glare within the optic 40 .
  • FIGS. 7-9 each illustrates one half of an optic of an IOL in section having a configuration that reduces glare.
  • incoming light is refracted so as to decrease the probability of light reflecting off the peripheral edge surfaces toward the optical axis relative to conventional lenses.
  • incoming light reflects off of an internal peripheral edge surface at a shallow angle of incidence not toward the optical axis so as to decrease the probability of light reflecting off of other edge surfaces relative to conventional lenses.
  • All of the optics disclosed in FIGS. 7-9 comprise an optical axis OA, a convex anterior face AF, and a convex posterior face PP.
  • An optic 90 seen in FIG. 7 includes a peripheral edge 92 having a first edge surface 94 that is linear and substantially parallel to the optical axis OA, and an anteriorly-facing second edge surface 96 that is linear and non-parallel to the optical axis.
  • the anteriorly-facing second edge surface 96 is angled in the counter-clockwise (ccw) direction with respect to the optical axis OA.
  • the edge surfaces 94 and 96 meet in the mid-portion of the peripheral edge 92 at a discontinuity 98 .
  • a posterior edge corner 100 separates the peripheral edge 92 from posterior face PF, while an anterior edge corner 102 separates the peripheral edge from a peripheral land 104 that is substantially perpendicular to the optical axis.
  • An incoming light ray 106 is illustrated passing through the peripheral land 104 to reflect off the second edge surface 96 within the optic 90 .
  • the resulting reflected ray 108 is deflected through the optic 90 so that it misses the first edge surface 94 .
  • a substantial portion of the light entering the optic 90 in the region of the peripheral edge 92 is reflected at a relatively shallow angle of incidence off of the second edge surface 96 , and is not reflected off the first edge surface 94 toward the optical axis OA.
  • the anteriorly-facing second edge surface 96 is desirably angled at least about 10° with respect to the optical axis OA.
  • FIG. 8 illustrates an optic 110 having a peripheral edge 112 comprising a single anteriorly-facing edge surface 114 that is linear and non-parallel with respect to the optical axis OA.
  • the optic 110 has a single conical anteriorly-facing edge surface 114 .
  • a posterior edge corner 116 separates the edge surface 114 from the posterior face PF, and an anterior edge corner 118 separates the edge surface 114 from a peripheral land 120 that is substantially perpendicular to the optical axis OA.
  • An incoming light ray 122 is illustrated striking the peripheral land 120 and passing through the optic 110 .
  • the light ray may refract slightly on passage through the optic 110 , as indicated at 124 , but will not reflect off the surface edge 114 . That is, the posterior edge corner 116 is located farther radially outward from the optical axis OA than the anterior edge corner 118 and a substantial portion of light passing into the region of the peripheral edge 112 simply passes through the material of the optic 110 .
  • the anteriorly-facing edge surface 114 is desirably angled at least about 5° with respect to the optical axis OA.
  • FIG. 9 illustrates an optic 130 that is substantially similar to the optic 110 of FIG. 8 , with a peripheral edge 132 defined by a single anteriorly-facing edge surface 134 that is linear and non-parallel with respect to the optical axis OA.
  • the optic 130 has a single conical anteriorly-facing edge surface 134 .
  • a posterior edge corner 136 separates the peripheral edge 132 from the posterior face PF.
  • An anterior edge corner 138 separates the peripheral edge 132 from the anterior face AF, and there is no anterior peripheral land.
  • the path of a light ray 140 passing through the region of the peripheral edge 132 illustrates the elimination of any reflection off a peripheral edge surface.
  • the anteriorly-facing edge surface 134 is desirably angled at least about 5° with respect to the optical axis OA.
  • FIGS. 10-13 illustrate a number of optics of the present invention that are configured to transmit internal light radially outward from their peripheral edges as opposed to reflecting it toward the optical axis. This can be done in a number of ways, all of which result in light hitting the peripheral edge from the interior of the optic at an angle that is less than the critical angle for the refractive index of the lens material.
  • each of the optics in FIGS. 10-13 includes an optical axis OA, a convex anterior face AF, and a convex posterior face PF.
  • FIGS. 10 and 11 illustrate two substantially similar optics 150 a , 150 b that will be given corresponding element numbers.
  • Each of the optics 150 a , 150 b has a peripheral edge 152 b , 152 b defined by an edge surface 154 a , 154 b that is linear and substantially parallel to the optical axis OA.
  • a posterior edge corner 156 a , 156 b separates the edge surface 154 a , 154 b from the respective posterior face PF.
  • Both optics 150 a , 150 b include an acute anterior edge corner 158 a , 158 h separating the edge surface 154 a , 154 b from an anterior peripheral land 160 a , 160 b .
  • the peripheral lands 160 a , 160 b are shown as linear and non-perpendicular with respect to the optical axis OA, but it should be understood that non-linear lands may perform equally as well, and may further diffuse the incoming light.
  • the peripheral land 160 a of the optic 150 a of FIG. 10 joins with its anterior face AF at a discontinuity 162 .
  • a peripheral land 164 that is linear and substantially perpendicular to the optical axis OA joins the peripheral land 160 b of the optic 150 b of FIG. 11 to its anterior face AF; that is, there are two peripheral lands 160 b and 164 on the optic 150 b of FIG. 11 .
  • Incoming light rays 166 a , 166 b are illustrated in FIGS. 10 and 11 striking the respective peripheral lands 160 a , 160 b and passing through the material of the respective optics 150 a , 150 b toward the edge surfaces 154 a , 154 b . Because of the particular angle of the peripheral lands 160 a , 160 b , the light rays strike the edge surfaces 154 a , 154 b at angles that are less than the critical angle for the refractive index of the lens material.
  • the light rays pass through the peripheral edges 152 a , 152 b as indicated by the exit rays 168 a , 168 b .
  • the included angles between the edge surfaces 154 a , 154 b and the peripheral lands 160 a , 160 b are shown ⁇ 1 and ⁇ 2 . These angles are preferably less than 90°, more preferably within the range of about 45° to 88°, and most preferably within the range of about 70° to 88°. Of course, these ranges may differ depending on the refractive index of the material.
  • FIGS. 12 and 13 illustrate similar optics 170 a , 170 b that each have a peripheral edge 172 a , 172 b defined by a posteriorly-facing edge surface 174 a , 174 T that is linear and non-parallel with respect to the optical axis OA.
  • a posterior edge corner 176 a , 176 b separates the edge surface 174 a , 174 b from the posterior face PF.
  • an anterior edge corner 178 a separates the edge surface 174 a from the anterior face AF, without a peripheral land.
  • FIG. 12 illustrate similar optics 170 a , 170 b that each have a peripheral edge 172 a , 172 b defined by a posteriorly-facing edge surface 174 a , 174 T that is linear and non-parallel with respect to the optical axis OA.
  • a posterior edge corner 176 a , 176 b separates the edge surface 174 a , 174 b from the
  • an anterior edge corner 178 b separates the edge surface 174 b from a peripheral land 180 that is linear and substantially perpendicular to the optical axis OA of the optic 170 b .
  • the peripheral land 180 meets the anterior face AF at a discontinuity 182 .
  • the angles of the anterior edge corners 178 a and 178 b are indicated at ⁇ 1 and ⁇ 2 .
  • the magnitude of the angle ⁇ 1 depends both on the convexity of the anterior face AF and the angle of the posteriorly-facing edge surface 174 a with respect to the optical axis OA.
  • the anterior face AF may have widely differing convexities, but desirably the posteriorly-facing edge surface 174 a is at least 2° (clockwise in the drawing) with respect to the optical axis OA. Therefore, the angle ⁇ 1 is preferably less than about 120°, and more preferably are within the range of about 70° to 120°.
  • the peripheral land 180 is shown as linear and perpendicular with respect to the optical axis OA, but it should be understood that non-linear and non-parallel lands may perform equally as well.
  • the posteriorly-facing edge surface 174 b is at least 2° (clockwise in the drawing) with respect to the optical axis OA. Therefore, the angle ⁇ 2 is preferably acute, and more preferably is within the range of about 30° to 88°. Of course, these ranges may differ depending on the refractive index of the material.
  • FIGS. 12 and 13 illustrate incoming light rays 184 a , 184 b that strike the anterior side of the respective optic 170 a , 170 b adjacent the peripheral edges 172 a , 172 b and subsequently pass through the material of the optic and through the edge surfaces 174 a , 174 b without reflection.
  • this phenomenon is caused by the angles at which the light rays strike the edge surfaces 174 a , 174 b , which are lower than the critical angle for the refractive index of the lens material.
  • the light rays simply pass through the peripheral edges 172 a , 172 b without reflecting back towards the optical axis OA.
  • FIG. 14 a illustrates a further embodiment of an IOL 200 of the present invention having an optic 202 and a plurality of fixation members 204 extending radially outward therefrom, only one of which is shown.
  • FIG. 14 b is an enlargement of a peripheral edge region of the optic 202 .
  • the optic 202 includes an optical axis OA, a convex anterior face AF, and a convex posterior face PF.
  • the optic 202 includes a peripheral edge 206 defined by an anteriorly-facing edge surface 208 that is linear and non-parallel with respect to the optical axis OA.
  • a curved or rounded transition surface 210 smoothly blends the linear edge surface 208 to the convex anterior face AF.
  • An acute posterior edge corner 212 separates the edge surface 208 from a peripheral land 214 that is linear and substantially perpendicular to the optical axis OA.
  • the peripheral land 214 joins with the convex posterior face PF at a discontinuity 216 .
  • FIG. 14 a illustrates a plane 218 coincident with the circular posterior edge corner 212 . This plane represents a separation line between two mold halves used to form the optic 202 . In this manner, the acute peripheral edge corner 212 can be easily formed between the mold halves.
  • FIGS. 14 a and 14 b incorporates a combination of several advantageous features previously described. That is, the rounded transition surface 210 tends to diffuse light rays entering from the anterior side, as described above with respect to the embodiment of FIGS. 3-5 .
  • the edge surface 208 is angled in such a manner that some of the light passing through the transition surface 210 will not even strike it, and the light that does will be reflected at a relatively shallow angle of incidence that reduces glare.
  • FIGS. 15-17 illustrate the peripheral edges of three optics 220 a , 220 b , 220 c having similar shapes.
  • the optic 220 a of FIG. 15 has a peripheral edge defined by an anteriorly-facing surface 222 a that is linear and non-parallel with respect to the optical axis, an acute posterior edge corner 224 a , and a rounded anterior transition surface 226 a blending with the anterior face AF.
  • a peripheral land 228 a that is generally perpendicular with respect to the optical axis extends between the posterior face PF and the edge corner 224 a , and joins with the posterior face PF at a discontinuity 230 a .
  • the included angle between the surface 222 a and the peripheral land 228 a is relatively small, and the rounded transition surface 226 a protrudes slightly outward from the surface 222 a.
  • the peripheral edge of the optic 220 b shown in FIG. 16 also includes an anteriorly-facing surface 222 b that is linear and non-parallel with respect to the optical axis, an acute posterior edge corner 224 b , and a rounded anterior transition surface 226 b blending with the anterior face AF.
  • a peripheral land 228 b that is not perpendicular to the optical axis extends between the posterior face PF and the edge corner 224 b .
  • the peripheral land 228 b joins with the posterior face PF at a discontinuity 230 b .
  • the included angle between the surface 222 b and the peripheral land 228 b is slightly larger than that shown in FIG. 15 , primarily because the surface 222 b has a shallower angle with respect to the optical axis than the surface 222 a.
  • the peripheral edge of the optic 220 c shown in FIG. 17 also includes an anteriorly-facing surface 222 c that is linear and non-parallel with respect to the optical axis, an acute posterior edge corner 224 e , and a rounded anterior transition surface 226 c blending with the anterior face AF.
  • a peripheral land 228 c that is not perpendicular to the optical axis extends between the posterior face PF and the edge corner 224 c .
  • the peripheral land 228 c joins with the posterior face PF at a discontinuity 230 c .
  • the optic 220 c is fairly similar to the optic 220 b , but has a slightly less convex posterior face PF.
  • FIG. 18 illustrates the peripheral edge of an optic 240 having a saw-tooth or baffled edge surface 242 .
  • the edge surface 242 is generally aligned to face the anterior side of the optic 240 and includes multiple tooth facets or surfaces 244 a and 244 b defining peaks 246 and troughs 248 .
  • Each tooth surface 244 a is desirably parallel to the other surfaces on the same side of each tooth, as is each tooth surface 244 b with respect to the others on the other side of each tooth.
  • the peripheral edge of the optic 240 further includes a posterior edge corner 250 and a rounded transition surface 252 blending into the anterior face AF.
  • a peripheral land 254 that is generally perpendicular to the optical axis extends between the posterior face PF and the edge corner 250 .
  • edge surface 242 is angled so as to be non-parallel with respect to the optical axis, and thus some of the light rays internal to the optic 240 will not even strike this edge surface to further reduce glare.
  • FIG. 19 An optic 260 that includes a linear posteriorly-facing edge surface 262 is seen in FIG. 19 .
  • the peripheral edge of the optic 260 comprises the edge surface 262 , a rounded transition surface 264 blending to the anterior face AF, and a peripheral edge corner 266 adjacent a short peripheral land 268 .
  • the advantages of the posteriorly-facing edge surface 262 were described previously with respect to FIGS. 12 and 13 , and primarily involved light being transmitted through the edge surface as opposed to being internally reflected off of it. Of course, light that is transmitted through the edge surface 262 as opposed to being reflected off of it cannot contribute to glare.
  • the rounded transition surface 264 helps to diffuse light rays striking the peripheral edge, thus further reducing glare.
  • FIG. 20 illustrates an optic 280 having both an anterior edge corner 282 and posterior edge corner 284 .
  • a posteriorly-facing edge surface 286 extends from the anterior edge corner 282 to an apex 288
  • an anteriorly-facing edge surface 290 extends between the apex and the posterior edge corner 284 .
  • the apex 288 defines the midpoint of a groove, and the resulting configuration in cross-section is something like a forked-tongue.
  • a pair of peripheral lands 292 a , 292 b extends between the edge corners 282 , 284 and the respective anterior and posterior faces of the optic 280 .
  • the peripheral lands 292 a , 292 b are desirably perpendicular to the optical axis.
  • the provision of linear edge surfaces that are non-parallel with respect to the optical axis helps reduce glare within the optic 280 .
  • the relatively sharp edge corners 282 , 284 helps reduce PCO by inhibiting cell growth on both the anterior and posterior sides of the optic 280 .
  • FIG. 21 Another embodiment of the invention seen in FIG. 21 has an optic 300 with an anterior face 302 , a posterior face 304 , an anterior peripheral region 306 , a posterior peripheral region 308 and a peripheral edge surface 310 .
  • the peripheral edge surface 310 has a continuously curved, concave configuration, for example, in cross-section.
  • the peripheral edge surface 310 intersects anterior peripheral region 306 at anterior peripheral corner edge 312 at an angle of about 70°. Corner edge 312 is at a discontinuity between anterior face 302 (anterior peripheral region 306 ) and peripheral edge surface 310 , and circumscribes optical axis 314 .
  • Peripheral edge surface 310 intersects posterior peripheral region 308 at posterior peripheral corner edge 316 at an angle of about 70° Corner edge 316 is at a discontinuity between posterior face 304 (posterior peripheral region 308 ) and peripheral edge surface 310 , and circumscribes optical axis 314 .
  • the anterior and posterior peripheral regions 306 and 308 extend radially inwardly, for example, for a distance of about 0.1 mm to about 1.0 mm or more (about 0.5 mm as shown in FIG. 21 ), from the peripheral edge surface 310 , and peripheral corner edge 312 and 316 respectively, and are substantially planar, more particularly, substantially perpendicular to the optical axis 314 of optic 300 .
  • Anterior face 302 includes an additional anterior region 318 which is convex, not planar.
  • Posterior face 304 includes an additional posterior region 320 which also is convex, not planar.
  • the dimension of optic 300 between anterior face 302 and posterior face 304 at the peripheral regions 306 and 308 is smaller than the same dimension at the optical axis 314 .
  • an IOL having the optic 300 in the capsular bag of an eye effectively inhibits or retards cell migration or growth, for example, epithelial cell migration or growth, from the eye onto and/or over the anterior and posterior faces 302 and 304 of optic 300 .
  • a reduced amount of edge glare is obtained with an IOL having the optic 300 implanted in the capsular bag of the eye.
  • an IOL having the optic 300 provides for inhibition of cell migration or growth onto and/or over the optic 300 because of the sharp or abrupt peripheral corner edges 312 and 316 .
  • the cells from the eye have a reduced tendency to grow onto and/or over the anterior face 302 and posterior face 304 relative to a substantially identical IOL without such peripheral corner edge.
  • the reduced glare obtained using an IOL having the optic 300 results from the curved configuration of the peripheral edge surface 310 .
  • an IOL having the optic 300 including the substantially continuously curved peripheral edge surface 310 provides reduced glare relative to a substantially similar IOL having a peripheral edge surface which is substantially parallel, for example, in cross-section, to the optical axis of the IOL.
  • FIG. 22 illustrates an alternate embodiment of an IOL in accordance with the present invention.
  • This IOL has an optic shown generally at 330 .
  • optic 330 is structured and functions similarly to optic 300 .
  • anterior face 332 is convex throughout, and optic 330 does not include a substantially planar anterior peripheral region. This convex anterior face 332 intersects peripheral edge surface 336 at sharp anterior peripheral corner edge 338 .
  • posterior face 334 is convex throughout, and optic 330 does not include a substantially planar posterior peripheral region. This convex posterior face 334 intersects peripheral edge surface 336 at sharp posterior peripheral corner edge 340 .
  • anterior face 332 and posterior face 334 can be independently provided to address the needs of any given specific application including the following factors; the vision correction or corrections desired, the size of optic 330 , the size of the eye in which an IOL having optic 330 is to be placed and the like factors.
  • Optic 330 inhibits or retards cell migration or growth and provides a reduced amount of edge glare as does the optic 300 , described above.
  • FIG. 23 illustrates a further embodiment of an IOL in accordance with the present invention.
  • This IOL has an optic shown generally at 350 .
  • optic 350 is structured and functions similarly to optic 330 .
  • the principal difference between optic 350 and optic 330 relates to the shape of peripheral edge surface 352 .
  • the curvature of peripheral edge surface 352 is more complex relative to the curvature of peripheral edge surface 336 .
  • the curvature of edge surface 352 varies substantially continuously while the curvature of edge surface 336 is a substantially constant concave arc (in cross-section).
  • Peripheral edge surface 352 is configured to reduce the amount of edge glare obtained with optic 350 in the eye relative to, for example, IOL 30 of FIG. 2 .
  • the specific configuration or curvature of peripheral edge surface 352 is provided to address the needs of a specific application, including the following factors: the size of the optic 350 , the size of the eye in which an IOL having the optic 330 is to be placed and the like factors.
  • FIG. 24 illustrates an additional embodiment of the present invention.
  • the IOL illustrated in FIG. 24 has an optic shown generally at 360 .
  • optic 360 is structured and functions similarly to optic 330 .
  • the primary difference between optic 360 and optic 330 relates to the configuration of peripheral edge surface 362 .
  • the curvature of peripheral edge surface 362 varies substantially continuously (in a manner which is substantially the reverse of the curvature of peripheral edge surface 352 of optic 350 ) while the curvature of edge 336 is a substantially constant concave arc (in cross-section).
  • the peripheral edge surface 362 of optic 360 is effective in reducing the glare caused by the presence of optic 360 in the eye relative to the glare obtained with IOL 30 of FIG. 2 in the eye.
  • FIG. 25 illustrates an additional embodiment of an IOL in accordance with the present invention. Except as expressly described herein, this IOL, having an optic shown generally at 370 is structured and functions similarly to optic 330 .
  • peripheral edge surface 372 includes a first portion 374 which is concave relative to the optical axis 376 of optic 370 .
  • Peripheral edge surface 372 also includes a second portion 378 which is convex relative to the optical axis 376 of optic 370 .
  • the curvature of the peripheral edge surface of the present IOLs for example, peripheral edge surface 372 of optic 370 , can be relatively complex.
  • Peripheral edge surface 372 is effective to provide reduced glare in the eye relative to IOL 30 of FIG. 2 .
  • peripheral edge surface 372 intersects anterior face 380 at anterior peripheral corner edge 382 at an angle of about 90°.
  • peripheral edge surface 372 intersects posterior peripheral region 384 at posterior peripheral corner edge 386 at an angle of about 90°.
  • Optic 370 is effective in inhibiting or retarding cell migration or growth from the eye onto or over the optic 370 .
  • FIG. 26 illustrates a further alternate embodiment of an IOL in accordance with the present invention.
  • This IOL has an optic shown generally at 400 .
  • optic 400 is structured and functions substantially similarly to optic 330 .
  • peripheral edge surface 402 has a continuously curved configuration somewhat similar to peripheral edge surface 372 of optic 370 .
  • the anterior face 404 intersects peripheral edge surface 402 on a curve (that is on a continuity not at a discontinuity). In other words, the intersection of anterior face 404 and peripheral edge surface 402 is smooth or continuous, not sharp or discontinuous.
  • Optic 400 is effective in reducing the amount of glare obtained with optic 400 in the eye relative to IOL 30 of FIG. 2 in the eye. Also, optic 370 is effective in retarding or inhibiting migration from the eye onto and/or over cell growth or migration from the eye onto and/or over the posterior face 406 of optic 400 .
  • FIG. 27 illustrates a still further embodiment of an IOL in accordance with the present invention. Except as expressly described herein, this IOL, having an optic shown generally at 410 is structured and functions similarly to optic 330 .
  • peripheral edge surface 412 is convex relative to the optical axis 416 of optic 410 .
  • Peripheral edge surface 412 does not intersect anterior face 418 at a sharp or discontinuous corner edge, but does intersect posterior face 414 at an obtuse angle at posterior peripheral corner 420 .
  • Posterior face 414 includes a peripheral region 422 which is substantially perpendicular to optical axis 416 .
  • Anterior face 418 includes a peripheral region 424 which is roughened to be at least partially opaque to the transmission of light. The combination of the convex peripheral edge surface 412 and the at least partially opaque peripheral region 424 is particularly effective in reducing glare, for example, from corner 420 , obtained with an IOL having optic 410 in the eye.
  • FIG. 28 illustrates still another embodiment of an IOL in accordance with the present invention.
  • This TOL has an optic shown generally at 440 .
  • optic 440 is structured and functions substantially similarly to optic 330 .
  • Peripheral edge surface 442 includes a first portion 448 which is convex relative to optic axis 450 of optic 440 .
  • Peripheral edge surface 442 also includes a second portion 452 which transitions from first portion 448 and intersects posterior face 446 at corner 454 .
  • Peripheral edge surface 442 does not intersect anterior face 444 at a sharp or discontinuance corner edge.
  • Posterior face 446 includes a peripheral region 456 which is substantially perpendicular to optical axis 450 .
  • Anterior face 444 includes the peripheral region 458 which is roughened to be at least partially opaque to the transmission of light. Region 460 of peripheral edge surface 442 and region 462 of posterior face 446 are also roughened to be at least partially opaque to the transmission of light.
  • the combination of the peripheral edge surface 442 and the at least partially opaque regions 458 , 460 , 462 is particularly effective in reducing glare, for example, from corner edge 454 , obtained with optic 440 in the eye.
  • the edges and surfaces near the edges may be “textured” or frosted to cause scatter of light impinging on the peripheral region. Such scattering helps reduce edge glare.
  • use of texture in combination with various edge geometries may help reduce PCO.
  • Various texturing regimens may be used, as described in U.S. Pat. No. 5,693,094, entitled IOL for Reducing Secondary Opacification, hereby expressly incorporated by reference.
  • IOLs made of silicone desirably include texturing/frosting on at least one edge surface as well as on a peripheral region of the posterior face, or intermediate land.
  • Acrylic IOLs desirably include texturing/frosting on at least one edge surface, and preferably on an edge surface that is parallel to the optical axis.
  • the intraocular lenses of the present invention may be manufactured using a variety of techniques, including injection molding, compression molding, lathing, and milling. Those of skill in the art will understand how to form the mold dies, or program the cutting tools to shape the lenses in accordance with present invention. Importantly, care must be taken to avoid rounding the various corners or discontinuities for the particular optic during the polishing process. Therefore, the corners must be masked or otherwise protected while the lens is being polished. Alternatively, the unmasked lens may be polished and then the various edge surfaces re-cut to insure sharp corners.
  • the design of the fixation members 24 a , 24 b may play an important role in reducing the risk of PCO for any particular lens. That is, the fixation members 24 a , 24 b must be designed such that during capsular contraction, there is enough axial movement and accompanying bias of the lens against the posterior capsule to seal the capsule around the posterior edge corners of the lens.
  • a variety of fixation members 24 a , 24 b are known in the art that can provide the required posterior bias to the lens.
  • fixation members 24 a , 24 b may vary depending on the overall lens diameter, the diameter of the optic, the angle of the fixation member, the stiffness of the fixation member material, the gauge of the fixation member, the geometry of the fixation member, and the way in which the fixation member is attached to the lens,
  • the present invention very effectively provides IOLs which inhibit cell growth or migration, in particular epithelial cell growth or migration from a capsular bag, onto and/or over the IOL optics.
  • the IOLs produce reduced glare, in particular edge glare, relative to a lens having a peripheral edge which is substantially parallel, in cross-section, to the optical axis of the IOL optic.

Abstract

An intraocular lens implantable in an eye includes an optic for placement in the capsular bag of the eye and for directing light toward the retina of the eye. The optic has a central optical axis, an anterior face, an opposing posterior face and a peripheral edge between the faces. The peripheral edge has one or more curved or angled surfaces that reduce glare within the IOL. For instance, a rounded transition surface on the anterior side of the peripheral edge diffuses the intensity of reflected light, or a particular arrangement of straight edge surfaces refracts the light so as not to reflect, or does not reflect at all. The intersection of the peripheral edge and at least one of the anterior face and the posterior face, preferable both of such faces, forms a peripheral corner located at a discontinuity between the peripheral edge and the intersecting face or faces. The present IOLs inhibit cell growth from the eye in front of or in back of the optic and reduce glare obtained in the eye in which the IOL is located.

Description

    RELATED APPLICATION
  • The present application is a continuation of co-pending application Ser. No. 10/245,920, filed Sep. 18, 2002, which is continuation of application Ser. No. 09/507,602, filed Feb. 18, 2000, now U.S. Pat. No. 6,468,306, issued Oct. 22, 2002, which is a continuation of application Ser. No. 09/448,713, filed Nov. 24, 1999, now abandoned, which is a continuation-in-part of application Ser. No. 09/086,882, filed May 29, 1998, now U.S. Pat. No. 6,162,249, issued Dec. 19, 2000. The disclosure of each of these applications and patents is incorporated in its entirely by reference herein.
  • BACKGROUND OF THE INVENTION
  • This invention relates to intraocular lenses (IOLs) and, more particularly, to IOLs which inhibit migration or growth of cells from the eye onto the IOL and reduce glare in the eye.
  • An intraocular lens is commonly used to replace the natural lens of a human eye when warranted by medical conditions. It is common practice to implant an IOL in a region of the eye known as the capsular bag or posterior capsule.
  • One potential concern with certain IOLs following implantation is that cells from the eye, particularly epithelial cells from the capsular bag, tend to grow in front of and/or in back of the optic of the IOL. This tends to block the optic of the IOL and to impair vision.
  • A common treatment for this condition is to use a laser to destroy the cells and a central region of the capsular bag. Although this treatment is effective, the laser is expensive and is not available throughout the world. There is also cost associated with the laser treatment as well as some patient inconvenience and risk of complications. Finally, the laser treatment may affect the performance of some IOLs.
  • Another potential concern after certain IOLs are implanted has to do with glare caused by light reflecting off of the IOLs, in particular, the edges of IOLs. Such glare can be an annoyance to the patient and may even lead to removal and replacement of the IOL.
  • It would be advantageous to provide IOLs which inhibit growth of cells from the eye onto the IOLs and/or which reduce glare caused by the IOLs in the eye.
  • SUMMARY OF THE INVENTION
  • New IOLs have been discovered. Such IOLs are effective to inhibit cell growth, in particular epithelial cell growth, from the eye onto the optic of the IOLs. The IOLs are structured so as to reduce glare, in particular edge glare, in the eye resulting from the presence of the IOL. The present IOLs are straightforward in design and construction, are easily manufactured, can be implanted, or inserted in the eye using conventional techniques, and are effective and produce substantial benefits in use in the eye.
  • In one broad aspect of the present invention, the present IOLs are implantable in the eye and comprise an optic having a central optical axis, an anterior face, an opposing posterior face and a peripheral edge or edge surface between the faces. The optic is adapted for placement in the capsular bag of the eye and for directing light toward the retina of the eye. In a very useful embodiment, the IOLs further comprise at least one fixation member, preferably two fixation members, and more preferably two elongated fixation members, coupled to the optic for use in fixing the IOLs in the eye.
  • In a preferred aspect, the present invention provides a reduced-glare intraocular lens implantable in the eye and including an optic adapted for placement in the capsular bag of the eye for directing light toward the retina of the eye. The optic has a central optical axis, an anterior face, an opposing posterior face, and a peripheral edge. The peripheral edge has a least one surface with a linear cross-sectional configuration that is oriented other than parallel to the central optical axis. Further, the peripheral edge and the anterior face, and/or the peripheral edge and the posterior face, intersect to form at least one peripheral edge corner located at a discontinuity between the peripheral edge and the intersecting anterior or posterior face. The peripheral edge may also include a rounded transition surface on its anterior side, wherein the peripheral edge corner is provided only between the peripheral edge and intersecting posterior face. The peripheral edge may also include two linear surfaces angled with respect to one another, wherein the other linear surface may be oriented parallel to the optical axis.
  • In another aspect of present invention, a reduced-glare intraocular lens implantable in an eye comprises an optic adapted for placement in the capsular bag of the eye and for directing light toward the retina of the eye. The optic has a central optical axis, an anterior face, and a posterior face. An outer edge of the optic is defined by a peripheral edge that includes, in cross-section, a linear surface that is non-parallel with respect to the optical axis and a posterior corner defining the posterior limit of the peripheral edge. Advantageously, cell growth from the eye in front of or in back of the optic is more inhibited relative to a substantially identical intraocular lens without the posterior corner, and reduced glare is obtained in the eye relative to a substantially identical intraocular lens having a peripheral linear surface that is parallel to the central optical axis. The optic may also include a convex surface on the peripheral edge defining a transition surface between the anterior face and the linear surface. A second linear surface that is parallel with respect to the optical axis may also be provided. In addition, the optic may include first and second linear surfaces, wherein the first linear surface is anteriorly-facing and second linear surface is parallel with respect to the optical axis.
  • In still a further embodiment of the present invention, an intraocular lens implantable in an eye includes an optic adapted for placement in the capsular bag of the eye and for directing light toward the retina of the eye. The optic includes a peripheral edge extending between an anterior face and a posterior face consisting only of a conical surface. The conical surface may be posteriorly-facing, wherein the conical surface is sufficiently angled with respect to the optical axis so as to increase transmission of light from the optic through the conical surface relative to a substantially identical intraocular lens with a peripheral edge consisting only of a surface parallel to the optical axis. Alternatively, a peripheral land extends between the anterior face and conical surface, wherein the conical surface is generally posteriorly-facing and wherein the conical surface and the peripheral land adjacent the conical surface define an acute included angle. In a still further form, the conical surface may be anteriorly-facing, wherein the conical surface is sufficiently angled with respect to the optical axis so as to decrease the probability of light internal to the optic contacting the conical surface relative to a substantially identical intraocular lens with a peripheral edge consisting only of a surface parallel to the optical axis.
  • Another aspect of present invention is an intraocular lens including an optic defining a central optical axis, an anterior face, and a posterior face. A peripheral edge extending between the anterior face and the posterior face includes, in cross-section, a linear edge surface terminating at its anterior side in an anterior edge corner. An anterior land adjacent the anterior edge corner, wherein the linear edge surface and the anterior land define an acute included angle so as to increase transmission of light from the optic through the conical surface relative to a substantially identical intraocular lens with a linear edge surface and anterior land that define an included angle of 90° or more.
  • In a still further form, the present invention provides an intraocular lens having optic defining optical axis, an anterior face, and a posterior face. A peripheral edge stands between the anterior face and posterior face and includes, in cross-section, at least two linear edge surfaces that are not parallel to the optical axis. The two linear edge surfaces may be angled radially inwardly toward each other to meet an apex and together define a groove. Further, a plurality of such grooves may be provided by adjoining linear edge surfaces. A rounded transition surface extending between an anteriorly-facing edge surface and the anterior face of the optic may also be provided.
  • The peripheral edge of the present IOLs may have a substantially continuous curved configuration in the direction between the anterior and posterior faces of the optic, that is between the faces in a cross-sectional plane including the optical axis. Indeed, the entire peripheral edge may have a substantially continuous curved configuration in the direction between the anterior and posterior faces of the optic.
  • The peripheral edge of the present IOLs may have a curved surface, a flat surface that is either parallel to the optical axis or not, or a combination of flat and/or curved surfaces. For example, if a portion of the peripheral edge has a substantially continuous curved configuration, another portion, for example, the remaining portion, of the peripheral edge preferably has a linear configuration in the direction between the anterior and posterior faces of the optic which is not parallel to the optical axis.
  • The present IOLs preferably provide reduced glare in the eye relative to the glare obtained with a substantially identical IOL having a peripheral edge parallel (flat) to the central optical axis in the direction between the faces of the optic. One or more of at least part of the peripheral edge, a portion of the anterior face near the peripheral edge and a portion of the portion face near the peripheral edge may be at least partially opaque to the transmission of light, which opacity is effective in reducing glare. Such opacity can be achieved in any suitable manner, for example, by providing “frosting” or physically or chemically roughening selected portions of the optic.
  • In addition, the intersection of the peripheral edge and at least one or both of the anterior face and the posterior face forms a peripheral corner or corner edge located at a discontinuity between the peripheral edge and the intersecting face. Such peripheral corner, which may be considered a sharp, abrupt or angled peripheral corner, is effective in inhibiting migration or growth of cells from the eye onto the IOL. Preferably, the present IOLs, with one or two such angled peripheral corners, provide that cell growth from the eye in front of or in back of the optic is more inhibited relative to a substantially identical IOL without the sharp, abrupt or angled peripheral corner or corners.
  • The peripheral edge and the intersecting face or faces intersect at an angle or angles, preferably in a range of about 45° to about 135°, more preferably in a range of about 60° to about 120°. In one embodiment, an obtuse angle (that is greater than 90° and less than 180°) of intersection is provided. Such angles of intersection are very effective in facilitating the inhibition of cell migration or growth onto and/or over the anterior face and/or posterior face of the optic of the present IOL.
  • In one very useful embodiment, at least one, conceivably both, of the anterior face and the posterior face has a peripheral region extending from the peripheral edge toward the central optical axis. The peripheral region or regions preferably are substantially planar, and may or may not be substantially perpendicular to the central optical axis. Preferably, only the anterior face has a peripheral region extending from the peripheral edge toward the central optical axis which is substantially planar, more preferably substantially perpendicular to the central optical axis. The peripheral region preferably has a radial dimension of at least about 0.1 mm, and more preferably no greater than about 2 mm.
  • The dimension of the optic parallel to the central optical axis between the anterior face and the posterior face preferably is smaller at or near the peripheral edge, for example, at the peripheral region or regions, than at the central optical axis.
  • In one embodiment, at least a part or a portion of the peripheral edge surface of the optic is generally convex relative to the central optical axis. Alternately, at least a part or a portion of the peripheral edge surface of the optic is generally concave relative to the central optical axis. In a particularly useful embodiment, a first portion of the peripheral edge surface is generally convex relative to the central optical axis and a second portion of the peripheral edge surface is generally concave relative to the optical axis.
  • Preferably, the peripheral edge and/or the peripheral region or regions circumscribe the central optical axis. The anterior face and the posterior face preferably are both generally circular in configuration, although other configurations, such as oval, elliptical and the like, may be employed. At least one of the anterior and posterior faces has an additional region, located radially inwardly of the peripheral region, which is other than substantially planar.
  • Each and every combination of two or more features described herein is included within the scope of the present invention provided that such features are not mutually inconsistent.
  • The invention, together with additional features and advantages thereof, may best be understood by reference to the following description taken in connection with the accompanying illustrative drawings in which like parts bear like reference numerals.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • FIG. 1 is a plan view of one form of intraocular lens (IOL) constructed in accordance with the teachings of present invention.
  • FIG. 2 is a cross-sectional view of an optic of a prior art IOL.
  • FIG. 3 is an elevational view of an optic of an exemplary embodiment of an IOL of the present invention having a medium diopter value.
  • FIG. 4 is an elevational view of an optic of a further exemplary IOL of the present invention having a small diopter value.
  • FIG. 5 is an elevational view of an optic of a further exemplary IOL of the present invention having a large diopter value.
  • FIG. 6 is an elevational view of a peripheral edge region of the IOL of FIG. 3 showing the paths of a plurality of light rays passing therethrough.
  • FIG. 7 is a cross-sectional view of a peripheral edge region of an IOL of the present invention having an edge surface that is parallel to the optical axis, an anteriorly-facing edge surface that is not parallel to the optical axis and an anterior peripheral land that is perpendicular to the optical axis.
  • FIG. 8 is a cross-sectional view of a peripheral edge region of an IOL of the present invention having an anteriorly-facing edge surface not parallel to the optical axis and an anterior peripheral land perpendicular to the optical axis.
  • FIG. 9 is a cross-sectional view of a peripheral edge region of an IOL of the present invention having an anteriorly-facing edge surface that is not parallel to the optical axis and no peripheral land.
  • FIG. 10 is a cross-sectional view of a peripheral edge region of an IOL of the present invention having an edge surface that is parallel to the optical axis and an anterior peripheral land that is not perpendicular to the optical axis.
  • FIG. 11 is a cross-sectional view of a peripheral edge region of an IOL of the present invention having an edge surface that is parallel to the optical axis, an anterior peripheral land that is perpendicular to the optical axis, and an anterior peripheral land that is not perpendicular to the optical axis.
  • FIG. 12 is a cross-sectional view of a peripheral edge region of an IOL of the present invention having a posteriorly-facing edge surface that is not parallel to the optical axis and no peripheral land.
  • FIG. 13 is a cross-sectional view of a peripheral edge region of an IOL of the present invention having a posteriorly-facing edge surface that is not parallel to the optical axis and an anterior peripheral land that is perpendicular to the optical axis.
  • FIG. 14 a is a radial sectional view of an IOL of the present invention showing a fixation member extending from a peripheral edge.
  • FIG. 14 b is an elevational view of a peripheral edge region of the IOL of FIG. 14 a.
  • FIGS. 15-17 are elevational views of peripheral edge regions of IOLs of the present invention each having an anteriorly-facing edge surface that is not parallel to the optical axis, a rounded transition surface between the edge surface and the anterior face of the IOL, and a posterior peripheral land.
  • FIG. 18 is an elevational view of a peripheral edge region of an IOL of the present invention having a baffle structure disposed along an anteriorly-facing edge surface.
  • FIG. 19 is an elevational view of a peripheral edge region of an IOL of the present invention having an anteriorly-facing edge surface and a rounded transition surface between the edge surface and the anterior face of the IOL.
  • FIG. 20 is an elevational view of a peripheral edge region of an IOL of the present invention having both anteriorly- and posteriorly-facing edge surfaces.
  • FIG. 21 is a cross-sectional view of the optic of an alternative IOL of the present invention.
  • FIG. 22 is a cross-sectional view of the optic of an alternate embodiment of an IOL in accordance with the present invention.
  • FIG. 23 is a partial cross-sectional view of the optic of a further embodiment of an IOL in accordance with the present invention.
  • FIG. 24 is a partial cross-sectional view of an additional embodiment of an IOL in accordance with the present invention.
  • FIG. 25 is a partial cross-sectional view of the optic of another embodiment of an IOL in accordance with the present invention.
  • FIG. 26 is a partial cross-sectional view of the optic of a further alternate embodiment of an IOL in accordance with the present invention.
  • FIG. 27 is a partial cross-sectional view of the optic of a still further embodiment of an IOL in accordance with the present invention.
  • FIG. 28 is a partial cross-sectional view of the optic of still another embodiment of an IOL in accordance with the present invention.
  • DESCRIPTION OF THE PREFERRED EMBODIMENTS
  • FIG. 1 shows an IOL 20 which generally comprises an optic 22 and fixation members 24 a and 24 b. In this embodiment, the optic 22 may be considered as effective for focusing light on or near the retina of the eye. Optical axis 26 passes through the center of optic 22 in a direction generally transverse to the plane of the optic.
  • In this embodiment, the optic 22 is circular in plan and bi-convex approaching the optical axis 26. However, this configuration is merely illustrative as other configurations and shapes may be employed. The optic 22 may be constructed of any of the commonly employed materials used for rigid optics, such as polymethylmethacrylate (PMMA), or commonly employed materials used for resiliently deformable optics, such as silicone polymeric materials, acrylic polymeric materials, hydrogel-forming polymeric materials, mixtures thereof and the like.
  • The fixation members 24 a and 24 b in this embodiment are generally C-shaped and are integral with the optic 22. However, this is purely illustrative of the fixation members 24 a and 24 b as the fixation members may be of other configurations and/or may be separate members affixed to the optic 22 in any of a variety of conventional ways. Stated another way, the IOLs of the present invention may consist of one piece, with unitary optic and fixation members, or may be three or more pieces, with two or more fixation members connected to the optic. IOL 20 can be produced using conventional techniques well-known in the art.
  • Unless expressly described hereinafter, the general structural characteristics of IOL 20 apply to the other IOLs noted herein.
  • FIG. 2 illustrates an optic 30 of an IOL of the prior art having an optical axis OA, a convex anterior face AF, a convex posterior face PF, and a peripheral edge 32. The peripheral edge 32 is typically circular and has a constant cross-section circumscribing the optic 30. The optic 30 illustrated is of the square-cornered variety which provides some inhibition of cell growth onto the optic 30, a condition known as posterior capsule opacification (PCO). The peripheral edge 32 comprises an edge surface 34 that is parallel to the optical axis OA, and both anterior and posterior edge corners 36 a, 36 b, respectively. In addition, anterior and posterior lands 38 a, 38 b, extend between the anterior face AF and posterior face PF and respective edge corner 36 a or 36 b. Both the anterior and posterior lands 38 a, 38 b extend substantially perpendicularly with respect to the optical axis OA. Because of the parallel edge surface 34, the prior art optic 30 does not provide reduced edge glare as do the IOLs in accordance with the present invention.
  • In the present application, the terms anterior and posterior are used in their conventional sense; anterior refers to the front side of the eye, while posterior refers to the rear side. A number of surfaces of the intraocular lens of present invention are denoted either “anteriorly-facing” or “posteriorly-facing” to indicate their orientation with respect to the optical axis of the lens. For purpose of explanation, a surface that is parallel to the optical axis is neither anteriorly-facing or posteriorly-facing. A surface that is even slightly angled in one direction or the other can be identified with either the anterior or posterior side of the lens, depending on which side that surface faces.
  • FIG. 3 illustrates an optic 40 of an IOL of the present invention having an advantageous peripheral edge 42. The optic 40 defines an optical axis OA, a convex anterior face AF, and a convex posterior face PF. The peripheral edge 42 is desirably circular in shape, and has a constant cross-section circumscribing the optic 40. However, it should be understood by those skilled in the art that the peripheral edge 42 may not extend completely around the optic 40, and may be interrupted by alternative peripheral edge configurations, including combinations of peripheral edge configurations in accordance with the present invention.
  • The optic 40 is shown in elevational view to better illustrate the peripheral edge 42 in relation to the convex anterior face AF and posterior face PF. On the anterior side, the peripheral edge 42 includes a curved or rounded transition surface 44 leading to an anterior peripheral land or region 46 that is desirably linear and substantially perpendicular to the optical axis OA. On the posterior side, a discontinuous posterior edge corner 50 separates the peripheral edge 42 from the posterior face PF, with no peripheral land. The edge corner 50 defines the posterior limit of the peripheral edge 42. The peripheral edge 42 further comprises an edge surface 52 that is linear and substantially parallel to the optical axis OA adjacent the posterior edge corner 50, and an anteriorly-facing edge surface 54 that is linear and non-parallel to the optical axis OA adjacent the rounded transition surface 44. A shallow corner or discontinuity 56 separates the parallel edge surface 52 from the non-parallel edge surface 54.
  • In this respect, the term discontinuity refers to a transition between two peripheral edge surfaces that is visible as a corner or peripheral line on the optic. Of course, all corners ultimately have a radius, but discontinuity in this regard pertains only to a corner that is visible as a discrete line as opposed to a more rounded region. In turn, “visible” in this regard refers to visible as seen by the naked eye, or with the assistance of certain low-power magnification devices, such as an ocular. Another way to define corners in the presence sense is the intersection between two linear surfaces, at least with respect to the magnification shown in the drawings of the present application. Still another way to look at the effect of a discontinuity at the corner of the peripheral edge is that cell growth from the eye in front of or in back of the optic is more inhibited relative to a substantially identical intraocular lens without the discontinuity.
  • As used herein, the term “linear,” used to refer to various edge surfaces, is in all cases as viewed through the cross-section of the particular edge. That is, the lenses of the present invention are generally circular, and the peripheral edges thus defined circular surfaces of revolution. A linear cross-sectional edge can therefore defined a cylinder, or a conical surface. If the edge is parallel to the optical axis, the surface is cylindrical. On the other hand, if the surface is non-parallel with respect to the optical axis, the surface is conical. Therefore, a linear, non-parallel edge surface is conical, at least for a portion of the peripheral edge. It should be noted that, as mentioned above, the edge geometry around the periphery of any particular lens of the present invention may not be constant, and the edge surfaces disclosed herein should not be construed as necessarily extending in a constant configuration around the entire periphery of the lens.
  • Although the anterior peripheral land or region 46 is shown as being linear and substantially perpendicular to the optical axis OA, other configurations are contemplated. For example, the peripheral land 46 could be other than linear, i.e., convex or concave with respect to a plane through the medial plane of the optic. Or, the peripheral land 46 could be angled toward or away from the anterior side. Further, there may be more than one surface defining the peripheral land 46, such as a curved and a linear surface.
  • FIGS. 4 and 5 illustrate two further optics 60 a and 60 b that have substantially the same configuration as the optic 40 of FIG. 3. That is, both optics 60 a and 60 b have an optical axis OA, a convex anterior face AF, a convex posterior face PF, and a peripheral edge 62 a, 62 b, respectively. Each peripheral edge 62 a, 62 b, comprises, respectively, a rounded transition surface 64 a, 64 b, and anterior peripheral land 66 a, 66 b that is substantially perpendicular to the optical axis OA, a posterior edge corner 70 a, 70 b, an edge surface 72 a, 72 b that is substantially parallel to the optical axis OA, and an anteriorly-facing edge surface 74 a, 74 b that is non-parallel to the optical axis OA.
  • FIGS. 3, 4 and 5 illustrate optics of similar configuration that have different dimensions based on their different magnitude of optical correction, or diopter value. The optic 40 of FIG. 3 has an intermediate correction diopter value of 20, the optic 60 a of FIG. 4 has a diopter value of 10, and the optic 60 b of FIG. 5 has a diopter value of 30. These relative diopter values are reflected in the relative convexity of each. That is, the smallest diopter value optic 40 shown in FIG. 4 has relatively shallow convex anterior face AF and posterior face PF. In contrast, the larger diopter value optic 60 b in FIG. 5 has a larger convexity for both the anterior face AF and posterior face PF.
  • Various dimensions for the respective peripheral edges of the exemplary optics shown in FIGS. 3-5 are also given in FIGS. 4 and 5. That is, the thickness of each peripheral edge is given as t, the thickness of the parallel edge surface is given as A, the angle of the non-parallel edge surface is given as θ, and a radius of curvature of the transition surface is given as R.
  • The following tables provide exemplary values for these dimensions for the optics 60 a and 60 b of FIGS. 4 and 5. These dimensions are considered suitable for optics 60 a and 60 b that are made from silicone. It should be noted that the dimensions for the optic 40 of FIG. 3 are desirably approximately equal to those for the optic 60 b of FIG. 5. It should also be noted that the following dimensions are believed to provide certain benefits as far as reducing glare and PCO in IOLs, although not all the dimensions have been selected for either of those particular purposes. For example, some of the dimensions may be desirable to facilitate manufacturing of the respective IOL.
  • Table I provides exemplary values for optics that are made from acrylic.
    TABLE I
    EXEMPLARY DIMENSIONS FOR SILICONS IOLs
    T1 (in) t2 (in) A1 (in) A2 (in) Θ1 Θ2 R1 (in) R2 (in)
    .023- .012- .002- .002- 13- 13- .001- .004-
    .027 .014 .007 .007 17° 17° .003 .006
  • Table II provides exemplary values for the same dimensions as shown in FIGS. 4-5, but for optics that are made from acrylic. In this case, the subscript “1” pertains to optics having a diopter value of 10, while the subscript “2” pertains to optics having a diopter value of either 20 or 30.
    TABLE II
    EXEMPLARY DIMENSIONS FOR ACRYLIC IOLs
    t1 (in) t2 (in) A1 (in) A2 (in) Θ1 Θ2 R1 (in) R2 (in)
    .015- .013- .002- .002- 13- 13- .004- .004-
    .019 .017 .007 .007 17° 17° .008 .008
  • As is apparent from FIGS. 3-5, the convexity of the various lenses along the optical axis OA increases with increasing diopter value (the posterior face and especially the anterior face are more highly convex). However, some surgeons prefer the intraocular lenses to have approximately the same volume or center thickness at the optical axis regardless of diopter power. This permits the surgeon to use the same surgical technique across the diopter range. Therefore, the present invention contemplates varying the overall diameter of the optic for different diopter values. That is, the center thickness of the intraocular lenses for different diopter values remains the same regardless of diameter. Therefore, the diameter of lenses having greater convexity should be reduced to reduce the center thickness, and the diameter of flatter lenses should be increased, both to an intermediate value. For example, the diameter of the lower diopter value optic 60 a shown in FIG. 4 may be increased so that the center thickness is closer to the intermediate diopter value optic 40 shown in FIG. 3. Likewise, the diameter of the higher diopter value optic 60 b shown in FIG. 5 may be decreased so that the center thickness is closer to the optic 40 shown in FIG. 3.
  • Therefore, the present invention contemplates a set of intraocular lenses having varying diopter values wherein the diameter of the optics varies generally inversely (although not necessarily linearly) with respect to the diopter value. In this way, a set of intraocular lenses having approximately the same center thickness can be provided to the surgeon to help make the implantation procedure more consistent and predictable. One example of a set of intraocular lenses may include the optics shown in FIGS. 3-5. The lower diopter lens 60 a of FIG. 4 may have a diameter of approximately 6.25 mm, the intermediate diopter lens 40 of FIG. 3 may have a diameter of 6.0 mm, and the higher diopter lens 60 b of FIG. 5 may have a diameter of 5.75 mm. Advantageously, an increased diameter for lower diopter lenses corresponds to human physiology. That is, people who require lower diopter lenses typically have larger eyes, while people requiring high diopters tend to have smaller eyes.
  • FIG. 6 illustrates a section of the peripheral edge 42 of the optic 40 of FIG. 3 with a plurality of discrete light rays 80 a, 80 b, 80 c, entering the peripheral edge from the anterior side. The refracted/reflected path of each light ray through the peripheral edge 42 is indicated, with the path of each light ray as it exits the peripheral edge 42 indicated as 82 a, 82 b and 82 c.
  • FIG. 6 thus illustrates the advantageous characteristic of the peripheral edge 42 in diffusing incoming parallel light rays so that the reflected light intensity is reduced. That is, any light that ordinarily would reflect back towards the optical axis at near its original intensity is instead diffused to reduce glare in the IOL. The present invention contemplates utilizing a curved or rounded transition surface, such as the surface 44, in combination with one or more planar edge surfaces that are not parallel to the optical axis, such as the edge surface 54. In the illustrated embodiment, the peripheral edge 42 further includes the edge surface 52 that is substantially parallel to the optical axis. It is believed that the combination of the rounded transition surface 44 on the anterior side leading to the anteriorly-facing edge surface 54 substantially reduces glare within the optic 40.
  • FIGS. 7-9 each illustrates one half of an optic of an IOL in section having a configuration that reduces glare. In one design, incoming light is refracted so as to decrease the probability of light reflecting off the peripheral edge surfaces toward the optical axis relative to conventional lenses. In another design, incoming light reflects off of an internal peripheral edge surface at a shallow angle of incidence not toward the optical axis so as to decrease the probability of light reflecting off of other edge surfaces relative to conventional lenses. All of the optics disclosed in FIGS. 7-9 comprise an optical axis OA, a convex anterior face AF, and a convex posterior face PP.
  • An optic 90 seen in FIG. 7 includes a peripheral edge 92 having a first edge surface 94 that is linear and substantially parallel to the optical axis OA, and an anteriorly-facing second edge surface 96 that is linear and non-parallel to the optical axis. With respect to the partial cross-section of the optic 90 seen in FIG. 7, the anteriorly-facing second edge surface 96 is angled in the counter-clockwise (ccw) direction with respect to the optical axis OA. The edge surfaces 94 and 96 meet in the mid-portion of the peripheral edge 92 at a discontinuity 98. A posterior edge corner 100 separates the peripheral edge 92 from posterior face PF, while an anterior edge corner 102 separates the peripheral edge from a peripheral land 104 that is substantially perpendicular to the optical axis.
  • An incoming light ray 106 is illustrated passing through the peripheral land 104 to reflect off the second edge surface 96 within the optic 90. The resulting reflected ray 108 is deflected through the optic 90 so that it misses the first edge surface 94. In this manner, a substantial portion of the light entering the optic 90 in the region of the peripheral edge 92 is reflected at a relatively shallow angle of incidence off of the second edge surface 96, and is not reflected off the first edge surface 94 toward the optical axis OA. Thus, glare is reduced. To achieve this result, the anteriorly-facing second edge surface 96 is desirably angled at least about 10° with respect to the optical axis OA.
  • FIG. 8 illustrates an optic 110 having a peripheral edge 112 comprising a single anteriorly-facing edge surface 114 that is linear and non-parallel with respect to the optical axis OA. Thus, the optic 110 has a single conical anteriorly-facing edge surface 114. A posterior edge corner 116 separates the edge surface 114 from the posterior face PF, and an anterior edge corner 118 separates the edge surface 114 from a peripheral land 120 that is substantially perpendicular to the optical axis OA. An incoming light ray 122 is illustrated striking the peripheral land 120 and passing through the optic 110. Because of the anteriorly-facing angle of the edge surface 114, the light ray may refract slightly on passage through the optic 110, as indicated at 124, but will not reflect off the surface edge 114. That is, the posterior edge corner 116 is located farther radially outward from the optical axis OA than the anterior edge corner 118 and a substantial portion of light passing into the region of the peripheral edge 112 simply passes through the material of the optic 110. To achieve this result, the anteriorly-facing edge surface 114 is desirably angled at least about 5° with respect to the optical axis OA.
  • FIG. 9 illustrates an optic 130 that is substantially similar to the optic 110 of FIG. 8, with a peripheral edge 132 defined by a single anteriorly-facing edge surface 134 that is linear and non-parallel with respect to the optical axis OA. Thus, the optic 130 has a single conical anteriorly-facing edge surface 134. Again, a posterior edge corner 136 separates the peripheral edge 132 from the posterior face PF. An anterior edge corner 138 separates the peripheral edge 132 from the anterior face AF, and there is no anterior peripheral land. The path of a light ray 140 passing through the region of the peripheral edge 132 illustrates the elimination of any reflection off a peripheral edge surface. That is, a substantial portion of light striking the optic 130 from the anterior side simply passes through the optic without reflecting toward the optical axis OA. To achieve this result, the anteriorly-facing edge surface 134 is desirably angled at least about 5° with respect to the optical axis OA.
  • FIGS. 10-13 illustrate a number of optics of the present invention that are configured to transmit internal light radially outward from their peripheral edges as opposed to reflecting it toward the optical axis. This can be done in a number of ways, all of which result in light hitting the peripheral edge from the interior of the optic at an angle that is less than the critical angle for the refractive index of the lens material. Again, each of the optics in FIGS. 10-13 includes an optical axis OA, a convex anterior face AF, and a convex posterior face PF.
  • FIGS. 10 and 11 illustrate two substantially similar optics 150 a, 150 b that will be given corresponding element numbers. Each of the optics 150 a, 150 b has a peripheral edge 152 b, 152 b defined by an edge surface 154 a, 154 b that is linear and substantially parallel to the optical axis OA. A posterior edge corner 156 a, 156 b separates the edge surface 154 a, 154 b from the respective posterior face PF. Both optics 150 a, 150 b include an acute anterior edge corner 158 a, 158 h separating the edge surface 154 a, 154 b from an anterior peripheral land 160 a, 160 b. The peripheral lands 160 a, 160 b are shown as linear and non-perpendicular with respect to the optical axis OA, but it should be understood that non-linear lands may perform equally as well, and may further diffuse the incoming light. The peripheral land 160 a of the optic 150 a of FIG. 10 joins with its anterior face AF at a discontinuity 162. On the other hand, a peripheral land 164 that is linear and substantially perpendicular to the optical axis OA joins the peripheral land 160 b of the optic 150 b of FIG. 11 to its anterior face AF; that is, there are two peripheral lands 160 b and 164 on the optic 150 b of FIG. 11.
  • Incoming light rays 166 a, 166 b are illustrated in FIGS. 10 and 11 striking the respective peripheral lands 160 a, 160 b and passing through the material of the respective optics 150 a, 150 b toward the edge surfaces 154 a, 154 b. Because of the particular angle of the peripheral lands 160 a, 160 b, the light rays strike the edge surfaces 154 a, 154 b at angles that are less than the critical angle for the refractive index of the lens material. Therefore, instead of reflecting off of the edge surfaces 154 a, 154 b, the light rays pass through the peripheral edges 152 a, 152 b as indicated by the exit rays 168 a, 168 b. The included angles between the edge surfaces 154 a, 154 b and the peripheral lands 160 a, 160 b are shown α1 and α2. These angles are preferably less than 90°, more preferably within the range of about 45° to 88°, and most preferably within the range of about 70° to 88°. Of course, these ranges may differ depending on the refractive index of the material.
  • FIGS. 12 and 13 illustrate similar optics 170 a, 170 b that each have a peripheral edge 172 a, 172 b defined by a posteriorly-facing edge surface 174 a, 174T that is linear and non-parallel with respect to the optical axis OA. A posterior edge corner 176 a, 176 b separates the edge surface 174 a, 174 b from the posterior face PF. On the optic 170 a of FIG. 12, an anterior edge corner 178 a separates the edge surface 174 a from the anterior face AF, without a peripheral land. In contrast, as seen in FIG. 13 an anterior edge corner 178 b separates the edge surface 174 b from a peripheral land 180 that is linear and substantially perpendicular to the optical axis OA of the optic 170 b. The peripheral land 180 meets the anterior face AF at a discontinuity 182.
  • The angles of the anterior edge corners 178 a and 178 b are indicated at β1 and β2. The magnitude of the angle β1 depends both on the convexity of the anterior face AF and the angle of the posteriorly-facing edge surface 174 a with respect to the optical axis OA. The anterior face AF may have widely differing convexities, but desirably the posteriorly-facing edge surface 174 a is at least 2° (clockwise in the drawing) with respect to the optical axis OA. Therefore, the angle β1 is preferably less than about 120°, and more preferably are within the range of about 70° to 120°. The magnitude of the angle β2 seen in FIG. 13 depends both on the angle of the peripheral land 180 and the angle of the posteriorly-facing edge surface 174 b with respect to the optical axis OA. The peripheral land 180 is shown as linear and perpendicular with respect to the optical axis OA, but it should be understood that non-linear and non-parallel lands may perform equally as well. Desirably the posteriorly-facing edge surface 174 b is at least 2° (clockwise in the drawing) with respect to the optical axis OA. Therefore, the angle β2 is preferably acute, and more preferably is within the range of about 30° to 88°. Of course, these ranges may differ depending on the refractive index of the material.
  • FIGS. 12 and 13 illustrate incoming light rays 184 a, 184 b that strike the anterior side of the respective optic 170 a, 170 b adjacent the peripheral edges 172 a, 172 b and subsequently pass through the material of the optic and through the edge surfaces 174 a, 174 b without reflection. Again, this phenomenon is caused by the angles at which the light rays strike the edge surfaces 174 a, 174 b, which are lower than the critical angle for the refractive index of the lens material. As a result, the light rays simply pass through the peripheral edges 172 a, 172 b without reflecting back towards the optical axis OA.
  • FIG. 14 a illustrates a further embodiment of an IOL 200 of the present invention having an optic 202 and a plurality of fixation members 204 extending radially outward therefrom, only one of which is shown. FIG. 14 b is an enlargement of a peripheral edge region of the optic 202. As always, the optic 202 includes an optical axis OA, a convex anterior face AF, and a convex posterior face PF.
  • With reference to FIG. 14 b, the optic 202 includes a peripheral edge 206 defined by an anteriorly-facing edge surface 208 that is linear and non-parallel with respect to the optical axis OA. A curved or rounded transition surface 210 smoothly blends the linear edge surface 208 to the convex anterior face AF. An acute posterior edge corner 212 separates the edge surface 208 from a peripheral land 214 that is linear and substantially perpendicular to the optical axis OA. The peripheral land 214 joins with the convex posterior face PF at a discontinuity 216. FIG. 14 a illustrates a plane 218 coincident with the circular posterior edge corner 212. This plane represents a separation line between two mold halves used to form the optic 202. In this manner, the acute peripheral edge corner 212 can be easily formed between the mold halves.
  • The embodiment shown in FIGS. 14 a and 14 b incorporates a combination of several advantageous features previously described. That is, the rounded transition surface 210 tends to diffuse light rays entering from the anterior side, as described above with respect to the embodiment of FIGS. 3-5. In addition, the edge surface 208 is angled in such a manner that some of the light passing through the transition surface 210 will not even strike it, and the light that does will be reflected at a relatively shallow angle of incidence that reduces glare.
  • FIGS. 15-17 illustrate the peripheral edges of three optics 220 a, 220 b, 220 c having similar shapes. The optic 220 a of FIG. 15 has a peripheral edge defined by an anteriorly-facing surface 222 a that is linear and non-parallel with respect to the optical axis, an acute posterior edge corner 224 a, and a rounded anterior transition surface 226 a blending with the anterior face AF. A peripheral land 228 a that is generally perpendicular with respect to the optical axis extends between the posterior face PF and the edge corner 224 a, and joins with the posterior face PF at a discontinuity 230 a. The included angle between the surface 222 a and the peripheral land 228 a is relatively small, and the rounded transition surface 226 a protrudes slightly outward from the surface 222 a.
  • The peripheral edge of the optic 220 b shown in FIG. 16 also includes an anteriorly-facing surface 222 b that is linear and non-parallel with respect to the optical axis, an acute posterior edge corner 224 b, and a rounded anterior transition surface 226 b blending with the anterior face AF. A peripheral land 228 b that is not perpendicular to the optical axis extends between the posterior face PF and the edge corner 224 b. The peripheral land 228 b joins with the posterior face PF at a discontinuity 230 b. The included angle between the surface 222 b and the peripheral land 228 b is slightly larger than that shown in FIG. 15, primarily because the surface 222 b has a shallower angle with respect to the optical axis than the surface 222 a.
  • The peripheral edge of the optic 220 c shown in FIG. 17 also includes an anteriorly-facing surface 222 c that is linear and non-parallel with respect to the optical axis, an acute posterior edge corner 224 e, and a rounded anterior transition surface 226 c blending with the anterior face AF. A peripheral land 228 c that is not perpendicular to the optical axis extends between the posterior face PF and the edge corner 224 c. The peripheral land 228 c joins with the posterior face PF at a discontinuity 230 c. The optic 220 c is fairly similar to the optic 220 b, but has a slightly less convex posterior face PF.
  • FIG. 18 illustrates the peripheral edge of an optic 240 having a saw-tooth or baffled edge surface 242. The edge surface 242 is generally aligned to face the anterior side of the optic 240 and includes multiple tooth facets or surfaces 244 a and 244 b defining peaks 246 and troughs 248. Each tooth surface 244 a is desirably parallel to the other surfaces on the same side of each tooth, as is each tooth surface 244 b with respect to the others on the other side of each tooth. The peripheral edge of the optic 240 further includes a posterior edge corner 250 and a rounded transition surface 252 blending into the anterior face AF. A peripheral land 254 that is generally perpendicular to the optical axis extends between the posterior face PF and the edge corner 250.
  • Still with reference to FIG. 18, light striking the peripheral edge of the optic 240 from the anterior side is scattered and diffused upon passage through the baffled edge surface 242 and the rounded transition surface 252. This helps reduce glare within the optic 240. In addition, the edge surface 242 is angled so as to be non-parallel with respect to the optical axis, and thus some of the light rays internal to the optic 240 will not even strike this edge surface to further reduce glare.
  • An optic 260 that includes a linear posteriorly-facing edge surface 262 is seen in FIG. 19. The peripheral edge of the optic 260 comprises the edge surface 262, a rounded transition surface 264 blending to the anterior face AF, and a peripheral edge corner 266 adjacent a short peripheral land 268. The advantages of the posteriorly-facing edge surface 262 were described previously with respect to FIGS. 12 and 13, and primarily involved light being transmitted through the edge surface as opposed to being internally reflected off of it. Of course, light that is transmitted through the edge surface 262 as opposed to being reflected off of it cannot contribute to glare. In addition, the rounded transition surface 264 helps to diffuse light rays striking the peripheral edge, thus further reducing glare.
  • FIG. 20 illustrates an optic 280 having both an anterior edge corner 282 and posterior edge corner 284. A posteriorly-facing edge surface 286 extends from the anterior edge corner 282 to an apex 288, and an anteriorly-facing edge surface 290 extends between the apex and the posterior edge corner 284. The apex 288 defines the midpoint of a groove, and the resulting configuration in cross-section is something like a forked-tongue. A pair of peripheral lands 292 a, 292 b extends between the edge corners 282, 284 and the respective anterior and posterior faces of the optic 280. The peripheral lands 292 a, 292 b are desirably perpendicular to the optical axis. Again, the provision of linear edge surfaces that are non-parallel with respect to the optical axis helps reduce glare within the optic 280. Furthermore, the relatively sharp edge corners 282, 284 helps reduce PCO by inhibiting cell growth on both the anterior and posterior sides of the optic 280.
  • Another embodiment of the invention seen in FIG. 21 has an optic 300 with an anterior face 302, a posterior face 304, an anterior peripheral region 306, a posterior peripheral region 308 and a peripheral edge surface 310. The peripheral edge surface 310 has a continuously curved, concave configuration, for example, in cross-section. The peripheral edge surface 310 intersects anterior peripheral region 306 at anterior peripheral corner edge 312 at an angle of about 70°. Corner edge 312 is at a discontinuity between anterior face 302 (anterior peripheral region 306) and peripheral edge surface 310, and circumscribes optical axis 314. Peripheral edge surface 310 intersects posterior peripheral region 308 at posterior peripheral corner edge 316 at an angle of about 70° Corner edge 316 is at a discontinuity between posterior face 304 (posterior peripheral region 308) and peripheral edge surface 310, and circumscribes optical axis 314.
  • The anterior and posterior peripheral regions 306 and 308 extend radially inwardly, for example, for a distance of about 0.1 mm to about 1.0 mm or more (about 0.5 mm as shown in FIG. 21), from the peripheral edge surface 310, and peripheral corner edge 312 and 316 respectively, and are substantially planar, more particularly, substantially perpendicular to the optical axis 314 of optic 300. Anterior face 302 includes an additional anterior region 318 which is convex, not planar. Posterior face 304 includes an additional posterior region 320 which also is convex, not planar. The dimension of optic 300 between anterior face 302 and posterior face 304 at the peripheral regions 306 and 308 is smaller than the same dimension at the optical axis 314.
  • It is found that implanting an IOL having the optic 300 in the capsular bag of an eye effectively inhibits or retards cell migration or growth, for example, epithelial cell migration or growth, from the eye onto and/or over the anterior and posterior faces 302 and 304 of optic 300. In addition, it is found that a reduced amount of edge glare is obtained with an IOL having the optic 300 implanted in the capsular bag of the eye.
  • Without wishing to limit the invention to any particular theory of operation, it is believed that an IOL having the optic 300 provides for inhibition of cell migration or growth onto and/or over the optic 300 because of the sharp or abrupt peripheral corner edges 312 and 316. Thus, it is believed that the cells from the eye have a reduced tendency to grow onto and/or over the anterior face 302 and posterior face 304 relative to a substantially identical IOL without such peripheral corner edge. In addition, it is believed that the reduced glare obtained using an IOL having the optic 300 results from the curved configuration of the peripheral edge surface 310. Thus, an IOL having the optic 300 including the substantially continuously curved peripheral edge surface 310 provides reduced glare relative to a substantially similar IOL having a peripheral edge surface which is substantially parallel, for example, in cross-section, to the optical axis of the IOL.
  • FIG. 22 illustrates an alternate embodiment of an IOL in accordance with the present invention. This IOL has an optic shown generally at 330. Except as expressly described herein, optic 330 is structured and functions similarly to optic 300.
  • The principal difference between the optic 330 and the optic 300 relates to the shape of the anterior face 332 and the shape of posterior face 334. Specifically, anterior face 332 is convex throughout, and optic 330 does not include a substantially planar anterior peripheral region. This convex anterior face 332 intersects peripheral edge surface 336 at sharp anterior peripheral corner edge 338. Similarly, posterior face 334 is convex throughout, and optic 330 does not include a substantially planar posterior peripheral region. This convex posterior face 334 intersects peripheral edge surface 336 at sharp posterior peripheral corner edge 340. The specific configuration of anterior face 332 and posterior face 334 can be independently provided to address the needs of any given specific application including the following factors; the vision correction or corrections desired, the size of optic 330, the size of the eye in which an IOL having optic 330 is to be placed and the like factors. Optic 330 inhibits or retards cell migration or growth and provides a reduced amount of edge glare as does the optic 300, described above.
  • FIG. 23 illustrates a further embodiment of an IOL in accordance with the present invention. This IOL has an optic shown generally at 350. Except as expressly described herein, optic 350 is structured and functions similarly to optic 330.
  • The principal difference between optic 350 and optic 330 relates to the shape of peripheral edge surface 352. Specifically, the curvature of peripheral edge surface 352 is more complex relative to the curvature of peripheral edge surface 336. In particular, the curvature of edge surface 352 varies substantially continuously while the curvature of edge surface 336 is a substantially constant concave arc (in cross-section). Peripheral edge surface 352 is configured to reduce the amount of edge glare obtained with optic 350 in the eye relative to, for example, IOL 30 of FIG. 2. The specific configuration or curvature of peripheral edge surface 352 is provided to address the needs of a specific application, including the following factors: the size of the optic 350, the size of the eye in which an IOL having the optic 330 is to be placed and the like factors.
  • FIG. 24 illustrates an additional embodiment of the present invention. The IOL illustrated in FIG. 24 has an optic shown generally at 360. Except as expressly described herein, optic 360 is structured and functions similarly to optic 330.
  • The primary difference between optic 360 and optic 330 relates to the configuration of peripheral edge surface 362. Specifically, the curvature of peripheral edge surface 362 varies substantially continuously (in a manner which is substantially the reverse of the curvature of peripheral edge surface 352 of optic 350) while the curvature of edge 336 is a substantially constant concave arc (in cross-section). The peripheral edge surface 362 of optic 360 is effective in reducing the glare caused by the presence of optic 360 in the eye relative to the glare obtained with IOL 30 of FIG. 2 in the eye.
  • FIG. 25 illustrates an additional embodiment of an IOL in accordance with the present invention. Except as expressly described herein, this IOL, having an optic shown generally at 370 is structured and functions similarly to optic 330.
  • The primary difference between optic 370 and optic 330 relates to the configuration of the peripheral edge surface 372. Specifically, peripheral edge surface 372 includes a first portion 374 which is concave relative to the optical axis 376 of optic 370. Peripheral edge surface 372 also includes a second portion 378 which is convex relative to the optical axis 376 of optic 370. Thus, the curvature of the peripheral edge surface of the present IOLs, for example, peripheral edge surface 372 of optic 370, can be relatively complex. Peripheral edge surface 372 is effective to provide reduced glare in the eye relative to IOL 30 of FIG. 2. In addition, it should be noted that the peripheral edge surface 372 intersects anterior face 380 at anterior peripheral corner edge 382 at an angle of about 90°. Similarly, the peripheral edge surface 372 intersects posterior peripheral region 384 at posterior peripheral corner edge 386 at an angle of about 90°.
  • Optic 370, as with all of the IOLs in accordance with the present invention, is effective in inhibiting or retarding cell migration or growth from the eye onto or over the optic 370.
  • FIG. 26 illustrates a further alternate embodiment of an IOL in accordance with the present invention. This IOL has an optic shown generally at 400. Except as expressly described herein, optic 400 is structured and functions substantially similarly to optic 330.
  • The primary differences between optic 400 and optic 330 relate to the configuration of peripheral edge surface 402 and the configuration of the intersection between anterior face 404 and peripheral edge surface 402 of optic 400. Specifically, peripheral edge surface 402 has a continuously curved configuration somewhat similar to peripheral edge surface 372 of optic 370. Also, the anterior face 404 intersects peripheral edge surface 402 on a curve (that is on a continuity not at a discontinuity). In other words, the intersection of anterior face 404 and peripheral edge surface 402 is smooth or continuous, not sharp or discontinuous.
  • Optic 400 is effective in reducing the amount of glare obtained with optic 400 in the eye relative to IOL 30 of FIG. 2 in the eye. Also, optic 370 is effective in retarding or inhibiting migration from the eye onto and/or over cell growth or migration from the eye onto and/or over the posterior face 406 of optic 400.
  • FIG. 27 illustrates a still further embodiment of an IOL in accordance with the present invention. Except as expressly described herein, this IOL, having an optic shown generally at 410 is structured and functions similarly to optic 330.
  • The primary difference between optic 410 and optic 330 relates to the configuration of the peripheral edge surface 412 and to the configuration of posterior face 414. Specifically, peripheral edge surface 412 is convex relative to the optical axis 416 of optic 410. Peripheral edge surface 412 does not intersect anterior face 418 at a sharp or discontinuous corner edge, but does intersect posterior face 414 at an obtuse angle at posterior peripheral corner 420. Posterior face 414 includes a peripheral region 422 which is substantially perpendicular to optical axis 416. Anterior face 418 includes a peripheral region 424 which is roughened to be at least partially opaque to the transmission of light. The combination of the convex peripheral edge surface 412 and the at least partially opaque peripheral region 424 is particularly effective in reducing glare, for example, from corner 420, obtained with an IOL having optic 410 in the eye.
  • FIG. 28 illustrates still another embodiment of an IOL in accordance with the present invention. This TOL has an optic shown generally at 440. Except as expressly described herein, optic 440 is structured and functions substantially similarly to optic 330.
  • The primary differences between optic 440 and optic 330 relate to the configuration of peripheral edge surface 442, the configuration of the intersection between anterior face 444 and peripheral edge surface 442 of optic 440 and the configuration of posterior face 446. Peripheral edge surface 442 includes a first portion 448 which is convex relative to optic axis 450 of optic 440. Peripheral edge surface 442 also includes a second portion 452 which transitions from first portion 448 and intersects posterior face 446 at corner 454. Peripheral edge surface 442 does not intersect anterior face 444 at a sharp or discontinuance corner edge. Posterior face 446 includes a peripheral region 456 which is substantially perpendicular to optical axis 450. Anterior face 444 includes the peripheral region 458 which is roughened to be at least partially opaque to the transmission of light. Region 460 of peripheral edge surface 442 and region 462 of posterior face 446 are also roughened to be at least partially opaque to the transmission of light. The combination of the peripheral edge surface 442 and the at least partially opaque regions 458, 460, 462 is particularly effective in reducing glare, for example, from corner edge 454, obtained with optic 440 in the eye.
  • In addition to designing the geometry of the peripheral edge of the intraocular lenses of the present invention to reduce glare and posterior capsule opacification (PCO), the edges and surfaces near the edges may be “textured” or frosted to cause scatter of light impinging on the peripheral region. Such scattering helps reduce edge glare. In addition, use of texture in combination with various edge geometries may help reduce PCO. Various texturing regimens may be used, as described in U.S. Pat. No. 5,693,094, entitled IOL for Reducing Secondary Opacification, hereby expressly incorporated by reference. With respect to specific embodiments, IOLs made of silicone desirably include texturing/frosting on at least one edge surface as well as on a peripheral region of the posterior face, or intermediate land. Acrylic IOLs, on the other hand, desirably include texturing/frosting on at least one edge surface, and preferably on an edge surface that is parallel to the optical axis.
  • The intraocular lenses of the present invention may be manufactured using a variety of techniques, including injection molding, compression molding, lathing, and milling. Those of skill in the art will understand how to form the mold dies, or program the cutting tools to shape the lenses in accordance with present invention. Importantly, care must be taken to avoid rounding the various corners or discontinuities for the particular optic during the polishing process. Therefore, the corners must be masked or otherwise protected while the lens is being polished. Alternatively, the unmasked lens may be polished and then the various edge surfaces re-cut to insure sharp corners.
  • With reference back to FIG. 1, the design of the fixation members 24 a, 24 b may play an important role in reducing the risk of PCO for any particular lens. That is, the fixation members 24 a, 24 b must be designed such that during capsular contraction, there is enough axial movement and accompanying bias of the lens against the posterior capsule to seal the capsule around the posterior edge corners of the lens. A variety of fixation members 24 a, 24 b are known in the art that can provide the required posterior bias to the lens. The precise configuration of the fixation members 24 a, 24 b may vary depending on the overall lens diameter, the diameter of the optic, the angle of the fixation member, the stiffness of the fixation member material, the gauge of the fixation member, the geometry of the fixation member, and the way in which the fixation member is attached to the lens,
  • The present invention very effectively provides IOLs which inhibit cell growth or migration, in particular epithelial cell growth or migration from a capsular bag, onto and/or over the IOL optics. In addition, the IOLs produce reduced glare, in particular edge glare, relative to a lens having a peripheral edge which is substantially parallel, in cross-section, to the optical axis of the IOL optic. These benefits are achieved with IOLs which are easily manufactured and inserted in the eye. Such IOLs can be made of any suitable material, and provide effective performance and substantial benefits to the patient.
  • While this invention has been described with respect to various specific examples and embodiments, it is to be understood that the invention is not limited thereto and that it can be variously practiced within the scope of the following claims.

Claims (20)

1. An intraocular lens, comprising:
a centered optic sized and adapted for placement in the capsular bag of an eye and configured to direct light toward the retina of the eye, the optic having a central optical axis, an anterior face and an opposed posterior face, and a peripheral edge disposed about the central optical axis between the anterior face and posterior face, the peripheral edge comprising:
a linear edge portion;
a non-discontinuous convex portion comprising at least one curvature that is substantially greater than the curvature of the anterior face, the non-discontinuous convex portion smoothly blending the anterior face with the linear edge portion; and
a peripheral corner edge located at a discontinuity between the peripheral edge and the posterior face for inhibiting cell growth onto the optic.
2. The intraocular lens of claim 1, wherein the non-discontinuous convex portion has a substantially constant curvature.
3. The intraocular lens of claim 1, wherein the peripheral corner edge is located at a discontinuity between the linear edge portion and the posterior face.
4. The intraocular lens of claim 1, wherein peripheral edge further comprises a secondary linear edge surface disposed between the linear edge portion and the peripheral corner edge.
5. The intraocular lens of claim 4, wherein the secondary linear edge surface is substantially parallel to the central optical axis.
6. The intraocular lens of claim 4, wherein the linear edge portion and the secondary linear edge surface are disposed at different angles relative to the central optical axis.
7. The intraocular lens of claim 1, wherein the curvature is configured to reduce glare from incoming light rays.
8. The intraocular lens of claim 1, wherein the peripheral edge further comprises an anterior peripheral land that is substantially perpendicular to the optical axis and is disposed between the anterior face and the non-discontinuous convex portion.
9. The intraocular lens of claim 1, wherein the anterior face has a substantially constantly curved corrective portion centered on the optical axis and the optic further includes an anterior peripheral region between the corrective portion and the non-discontinuous convex portion of the peripheral edge.
10. The intraocular lens of claim 9, wherein the anterior peripheral region is at least partially opaque to the transmission of light to help reduce glare from incoming light rays.
11. The intraocular lens of claim 1, wherein the discontinuity between the peripheral edge and posterior face is formed where the peripheral edge and the posterior face intersect at an angle in a range of about 45° to about 135°.
12. The intraocular lens of claim 11, wherein the peripheral edge and the posterior face intersect at an angle in a range of about 60° to about 120°.
13. An intraocular lens, comprising:
a centered optic sized and adapted for placement in the capsular bag of an eye and configured to direct light toward the retina of the eye, the optic having a central optical axis, an anterior face and an opposed posterior face, and a peripheral edge disposed about the central optical axis between the anterior face and posterior face, the peripheral edge comprising:
a non-discontinuous convex portion comprising at least one curvature that is substantially greater than the curvature of the anterior face configured to reduce glare from incoming light rays; and
a peripheral corner edge located at a discontinuity between the peripheral edge and the posterior face for inhibiting cell growth onto the optic.
14. The intraocular lens of claim 13, wherein the non-discontinuous convex portion has a substantially constant curvature.
15. The intraocular lens of claim 13, wherein peripheral edge further comprises a linear edge portion disposed between the non-discontinuous convex portion and the peripheral corner edge.
16. The intraocular lens of claim 15, wherein the linear edge portion is substantially parallel to the central optical axis.
17. The intraocular lens of claim 13, wherein the peripheral edge further comprises an anterior peripheral land that is substantially perpendicular to the optical axis and is disposed between the anterior face and the non-discontinuous convex portion.
18. The intraocular lens of claim 13, wherein the anterior face has a substantially constantly curved corrective portion centered on the optical axis and the optic further includes an anterior peripheral region between the corrective portion and the non-discontinuous convex portion of the peripheral edge.
19. The intraocular lens of claim 18, wherein the anterior peripheral region is at least partially opaque to the transmission of light to help reduce glare from incoming light rays.
20. The intraocular lens of claim 13, wherein the peripheral edge and the posterior face intersect at an angle in a range of about 60° to about 120°.
US11/552,429 1998-05-29 2006-10-24 Intraocular lens for inhibiting cell growth and reducing glare Abandoned US20070106378A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US11/552,429 US20070106378A1 (en) 1998-05-29 2006-10-24 Intraocular lens for inhibiting cell growth and reducing glare
US14/181,146 US9949822B2 (en) 1998-05-29 2014-02-14 Intraocular lens for inhibiting cell growth and reducing glare

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US09/086,882 US6162249A (en) 1998-05-29 1998-05-29 IOI for inhibiting cell growth and reducing glare
US44871399A 1999-11-24 1999-11-24
US09/507,602 US6468306B1 (en) 1998-05-29 2000-02-18 IOL for inhibiting cell growth and reducing glare
US10/245,920 US7252683B2 (en) 1998-05-29 2002-09-18 Intraocular lens for inhibiting cell growth and reducing glare
US10/284,802 US20030130733A1 (en) 1998-05-29 2002-10-30 Novel intraocular lens for reducing glare
US11/552,429 US20070106378A1 (en) 1998-05-29 2006-10-24 Intraocular lens for inhibiting cell growth and reducing glare

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US10/284,802 Continuation US20030130733A1 (en) 1998-05-29 2002-10-30 Novel intraocular lens for reducing glare

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US14/181,146 Continuation US9949822B2 (en) 1998-05-29 2014-02-14 Intraocular lens for inhibiting cell growth and reducing glare

Publications (1)

Publication Number Publication Date
US20070106378A1 true US20070106378A1 (en) 2007-05-10

Family

ID=26775258

Family Applications (7)

Application Number Title Priority Date Filing Date
US09/507,602 Expired - Lifetime US6468306B1 (en) 1998-05-29 2000-02-18 IOL for inhibiting cell growth and reducing glare
US10/213,308 Abandoned US20030055498A1 (en) 1998-05-29 2002-08-06 IOL for inhibiting cell growth and reducing glare
US10/229,250 Abandoned US20030060879A1 (en) 1998-05-29 2002-08-27 IOL for inhibiting cell growth and reducing glare
US10/245,920 Expired - Fee Related US7252683B2 (en) 1998-05-29 2002-09-18 Intraocular lens for inhibiting cell growth and reducing glare
US10/284,802 Abandoned US20030130733A1 (en) 1998-05-29 2002-10-30 Novel intraocular lens for reducing glare
US11/552,429 Abandoned US20070106378A1 (en) 1998-05-29 2006-10-24 Intraocular lens for inhibiting cell growth and reducing glare
US14/181,146 Expired - Fee Related US9949822B2 (en) 1998-05-29 2014-02-14 Intraocular lens for inhibiting cell growth and reducing glare

Family Applications Before (5)

Application Number Title Priority Date Filing Date
US09/507,602 Expired - Lifetime US6468306B1 (en) 1998-05-29 2000-02-18 IOL for inhibiting cell growth and reducing glare
US10/213,308 Abandoned US20030055498A1 (en) 1998-05-29 2002-08-06 IOL for inhibiting cell growth and reducing glare
US10/229,250 Abandoned US20030060879A1 (en) 1998-05-29 2002-08-27 IOL for inhibiting cell growth and reducing glare
US10/245,920 Expired - Fee Related US7252683B2 (en) 1998-05-29 2002-09-18 Intraocular lens for inhibiting cell growth and reducing glare
US10/284,802 Abandoned US20030130733A1 (en) 1998-05-29 2002-10-30 Novel intraocular lens for reducing glare

Family Applications After (1)

Application Number Title Priority Date Filing Date
US14/181,146 Expired - Fee Related US9949822B2 (en) 1998-05-29 2014-02-14 Intraocular lens for inhibiting cell growth and reducing glare

Country Status (1)

Country Link
US (7) US6468306B1 (en)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5693094A (en) * 1995-05-09 1997-12-02 Allergan IOL for reducing secondary opacification
US6468306B1 (en) 1998-05-29 2002-10-22 Advanced Medical Optics, Inc IOL for inhibiting cell growth and reducing glare
US20060238702A1 (en) 1999-04-30 2006-10-26 Advanced Medical Optics, Inc. Ophthalmic lens combinations
FR2795944B1 (en) * 1999-07-08 2001-11-02 Corneal Ind INTRAOCULAR IMPLANT
US7204849B2 (en) * 2001-03-15 2007-04-17 Valdemar Portney Narrow profile intraocular lens
US6558419B1 (en) * 2001-11-08 2003-05-06 Bausch & Lomb Incorporated Intraocular lens
US20030120342A1 (en) * 2001-12-21 2003-06-26 Green George F. Intraocular lens
WO2003059196A2 (en) * 2002-01-14 2003-07-24 Advanced Medical Optics, Inc. Accommodating intraocular lens with elongated suspension structure
US7763069B2 (en) 2002-01-14 2010-07-27 Abbott Medical Optics Inc. Accommodating intraocular lens with outer support structure
US6648741B2 (en) * 2002-03-14 2003-11-18 Advanced Medical Optics, Inc. Apparatus for protecting the edge geometry of an intraocular lens during glass bead polishing process
US20050107874A1 (en) * 2002-03-18 2005-05-19 Ehud Assia Sharp angle intraocular lens optic
US7160324B2 (en) 2002-05-17 2007-01-09 Amo Groningen, B.V. Method in eye surgery
GB0217606D0 (en) * 2002-07-30 2002-09-11 Rayner Intraocular Lenses Ltd Intraocular lens
US7662180B2 (en) 2002-12-05 2010-02-16 Abbott Medical Optics Inc. Accommodating intraocular lens and method of manufacture thereof
US20040188872A1 (en) * 2003-03-31 2004-09-30 Jani Dharmendra M. Method for fabricating intraocular lens with peripheral sharp edge
JP4974527B2 (en) * 2003-04-28 2012-07-11 Hoya株式会社 Integrated intraocular lens and manufacturing method thereof
US20050033422A1 (en) 2003-08-08 2005-02-10 Advanced Medical Optics, Inc. Glare reducing rough surfaces
US7217289B2 (en) * 2003-09-12 2007-05-15 Minas Theodore Coronco Treatment of photic disturbances in the eye
CA2540166A1 (en) * 2003-09-30 2005-04-14 Bausch & Lomb Incorporated Intraocular lens for inhibiting pco and aco
US7144423B2 (en) * 2003-11-12 2006-12-05 Mcdonald Marguerite B Intraocular multifocal lens
US7615073B2 (en) * 2003-12-09 2009-11-10 Advanced Medical Optics, Inc. Foldable intraocular lens and method of making
US7813836B2 (en) * 2003-12-09 2010-10-12 Intouch Technologies, Inc. Protocol for a remotely controlled videoconferencing robot
US7621949B2 (en) 2003-12-09 2009-11-24 Advanced Medical Optics, Inc. Foldable intraocular lens and method of making
US20050131535A1 (en) 2003-12-15 2005-06-16 Randall Woods Intraocular lens implant having posterior bendable optic
FR2865381B1 (en) * 2004-01-28 2006-04-28 Corneal Ind INTRAOCULAR IMPLANT WITH FLEXIBLE OPTICS
US20050187621A1 (en) * 2004-02-24 2005-08-25 Brady Daniel G. Foldable unitary intraocular lens
US7569073B2 (en) * 2004-12-29 2009-08-04 Bausch & Lomb Incorporated Small incision intraocular lens with anti-PCO feature
US20070067031A1 (en) * 2005-09-22 2007-03-22 Alcon, Inc. Intraocular lens
US9636213B2 (en) 2005-09-30 2017-05-02 Abbott Medical Optics Inc. Deformable intraocular lenses and lens systems
US8709078B1 (en) * 2011-08-03 2014-04-29 Lockheed Martin Corporation Ocular implant with substantially constant retinal spacing for transmission of nerve-stimulation light
US20070244560A1 (en) * 2006-04-12 2007-10-18 Alexei Ossipov Intraocular lens with distortion free valve
US20080077238A1 (en) 2006-09-21 2008-03-27 Advanced Medical Optics, Inc. Intraocular lenses for managing glare, adhesion, and cell migration
US8568478B2 (en) 2006-09-21 2013-10-29 Abbott Medical Optics Inc. Intraocular lenses for managing glare, adhesion, and cell migration
US20080161914A1 (en) 2006-12-29 2008-07-03 Advanced Medical Optics, Inc. Pre-stressed haptic for accommodating intraocular lens
US20080269885A1 (en) * 2007-04-30 2008-10-30 Simpson Michael J IOL Peripheral Surface Designs to Reduce Negative Dysphotopsia
US20080269890A1 (en) * 2007-04-30 2008-10-30 Alcon Universal Ltd. Intraocular lens with peripheral region designed to reduce negative dysphotopsia
US20080269886A1 (en) * 2007-04-30 2008-10-30 Simpson Michael J IOL Peripheral Surface Designs to Reduce Negative Dysphotopsia
US20080269891A1 (en) * 2007-04-30 2008-10-30 Alcon, Inc. Intraocular lens with edge modification
US20080269882A1 (en) * 2007-04-30 2008-10-30 Alcon Universal Ltd. Intraocular lens with asymmetric optics
US8034108B2 (en) 2008-03-28 2011-10-11 Abbott Medical Optics Inc. Intraocular lens having a haptic that includes a cap
AU2010266022B2 (en) 2009-06-26 2015-04-23 Johnson & Johnson Surgical Vision, Inc. Accommodating intraocular lenses
WO2011017322A1 (en) 2009-08-03 2011-02-10 Abbott Medical Optics Inc. Intraocular lens for providing accomodative vision
RU2012127318A (en) * 2009-12-01 2014-01-20 Алькон Рисерч, Лтд. INTRAOCULAR LENS WITH EDGE EXECUTED WITH THE POSSIBILITY OF REDUCING THE DISTURBANCE OF THE REAR CAPSULE
NL2006307C2 (en) 2011-02-28 2012-08-29 Oculentis B V Ophthalmic lens having enhanced optical blending zone.
WO2012135077A2 (en) * 2011-03-25 2012-10-04 Eos Holdings, Llc Ophthalmic inspection lens
US9855136B2 (en) 2012-01-19 2018-01-02 Eyebright Medical Technology (Beijing) Co., Ltd. Posterior chamber intraocular lens
US9084674B2 (en) 2012-05-02 2015-07-21 Abbott Medical Optics Inc. Intraocular lens with shape changing capability to provide enhanced accomodation and visual acuity
EP2866736A1 (en) * 2012-06-29 2015-05-06 Abbott Medical Optics Inc. Reduced glare intraocular lens
RU2769301C2 (en) * 2012-12-06 2022-03-30 Алькон Инк. Design of edge for reducing unwanted light effects in intraocular lenses
US9805508B1 (en) * 2013-04-01 2017-10-31 Marvell International Ltd Active augmented reality display enhancement
US10383722B2 (en) * 2014-10-15 2019-08-20 Minas Theodore Coroneo Lens design
CN106901871B (en) * 2015-12-23 2021-08-24 爱博诺德(北京)医疗科技股份有限公司 Intraocular lens with one or more additional portions
AU2018330604A1 (en) 2017-09-11 2020-04-02 Amo Groningen B.V. Methods and apparatuses to increase intraocular lenses positional stability
TW201927263A (en) * 2017-12-18 2019-07-16 瑞士商諾華公司 Intraocular lens platform having improved haptic force distribution
TW202002915A (en) * 2018-04-06 2020-01-16 瑞士商愛爾康股份有限公司 Hybrid optical edge for an intraocular lens (IOL)
US11504226B2 (en) 2018-10-24 2022-11-22 Amo Groningen B.V. Intraocular lenses for reducing the risk of posterior capsule opacification
EP3861402A1 (en) * 2018-12-21 2021-08-11 Alcon Inc. Multi-curvature edge for ophthalmic lenses

Citations (98)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2110724A (en) * 1936-08-20 1938-03-08 Goettel Peter Waxing device
US3341490A (en) * 1964-08-13 1967-09-12 Dow Corning Blends of two polysiloxane copolymers with silica
US3457214A (en) * 1965-12-15 1969-07-22 Gen Electric Low temperature vulcanizing composition and article made therefrom
US3578850A (en) * 1970-02-11 1971-05-18 Alan H Grant Anti-flare contact lens
US4092743A (en) * 1976-10-04 1978-06-06 Kelman Charles D Intraocular lenses
US4168547A (en) * 1977-04-01 1979-09-25 Medicinska Akademia Anterior-chamber lens-carrier
US4189546A (en) * 1977-07-25 1980-02-19 Bausch & Lomb Incorporated Polysiloxane shaped article for use in biomedical applications
US4380643A (en) * 1981-08-24 1983-04-19 Asahi Glass Company, Ltd. Benzotriazole compound and homopolymer or copolymers thereof
US4402579A (en) * 1981-07-29 1983-09-06 Lynell Medical Technology Inc. Contact-lens construction
US4423809A (en) * 1982-02-05 1984-01-03 Staar Surgical Company, Inc. Packaging system for intraocular lens structures
US4424597A (en) * 1981-05-13 1984-01-10 Inprohold Establishment Posterior chamber implant lens
US4429421A (en) * 1982-02-03 1984-02-07 Levy Chauncey F Method of implanting an intraocular lens
US4435050A (en) * 1980-02-26 1984-03-06 Stanley Poler Contact lens assembly with haptic and method for making the same
US4435866A (en) * 1982-03-04 1984-03-13 Royden Brown Pollen trap for beehives with dual entranceways
US4440918A (en) * 1982-01-18 1984-04-03 Minnesota Mining And Manufacturing Company Contact lens containing a fluorinated telechelic polyether
US4439873A (en) * 1980-02-26 1984-04-03 Stanley Poler Intra-ocular lens construction
US4449267A (en) * 1982-05-26 1984-05-22 Siemion Edward D Floor seal strip
US4450593A (en) * 1981-11-09 1984-05-29 Lynell Medical Technology Inc. Intraocular and contact lens construction
US4468820A (en) * 1982-05-10 1984-09-04 Precision-Cosmet Co., Inc. Haptic attachment for intraocular lenses
US4470159A (en) * 1982-03-03 1984-09-11 Peyman Gholam A Keratoprosthesis
US4494254A (en) * 1982-05-03 1985-01-22 Osvaldo Lopez Intraocular lens
US4495361A (en) * 1983-04-29 1985-01-22 Bausch & Lomb Incorporated Polysiloxane composition with improved surface wetting characteristics and biomedical devices made thereof
US4521273A (en) * 1980-02-26 1985-06-04 Stanley Poler Method of making a lens and haptic assembly
US4525346A (en) * 1981-09-28 1985-06-25 Alcon Laboratories, Inc. Aqueous antimicrobial ophthalmic solutions
US4532267A (en) * 1984-02-15 1985-07-30 Board Of Regents, University Of Washington Vision correction lens made from an aminopolysaccharide compound or an ether or ester thereof
US4535141A (en) * 1984-03-23 1985-08-13 Dow Corning Corporation Liquid curable polyorganosiloxane compositions
US4535488A (en) * 1982-09-30 1985-08-20 Haddad Heskel M Anterior-posterior chamber intraocular lens
US4537943A (en) * 1983-07-21 1985-08-27 Innovative Surgical Products, Inc. Correction of defects in the eye and compositions therefor
US4541206A (en) * 1983-10-17 1985-09-17 Iolab Corp. Fixture for holding an optical lens during tumbling
US4562600A (en) * 1983-10-18 1986-01-07 Stephen P. Ginsberg Intraocular lens
US4570626A (en) * 1984-01-20 1986-02-18 Norris John L Corneal light shield
US4571040A (en) * 1980-02-26 1986-02-18 Lynell Medical Technology, Inc. Contact lens and haptic
US4573998A (en) * 1982-02-05 1986-03-04 Staar Surgical Co. Methods for implantation of deformable intraocular lenses
US4575373A (en) * 1984-11-02 1986-03-11 Johnson Don R Laser adjustable intraocular lens and method of altering lens power
US4580371A (en) * 1983-10-17 1986-04-08 Iolab Corporation Method for tumble grinding optical lens edge
US4585457A (en) * 1985-05-16 1986-04-29 Kalb Irvin M Inflatable intraocular lens
US4588406A (en) * 1985-08-15 1986-05-13 Fedorov Svjatoslav N Intraocular lens
US4597388A (en) * 1983-12-15 1986-07-01 Trutek Research, Inc. Apparatus for removing cataracts
US4601545A (en) * 1984-05-16 1986-07-22 Kern Seymour P Variable power lens system
US4608049A (en) * 1982-06-28 1986-08-26 Kelman Charles D Intraocular lens and method of inserting an intraocular lens into an eye
US4608050A (en) * 1983-07-21 1986-08-26 Innovative Surgical Products, Inc. Correction of defects in the eye and compositions therefor
US4636210A (en) * 1985-12-09 1987-01-13 Hoffer Kenneth J Multi-part intraocular lens and method of implanting it in an eye
US4647282A (en) * 1985-08-27 1987-03-03 Moskovsky Nauchno-Issledovatelsky Institut Mikrokhirurgii Glaza Material for ocular prosthetics
US4652622A (en) * 1983-04-29 1987-03-24 Bausch & Lomb Incorporated Polysiloxane composition with improved surface wetting characteristics and biomedical devices made thereof
US4657546A (en) * 1983-07-08 1987-04-14 Shearing Steven P Intraocular lens
US4661108A (en) * 1985-07-03 1987-04-28 Surgidev Corporation Intraocular lens
US4664667A (en) * 1982-06-28 1987-05-12 Kelman Charles D Deformable intraocular lens
US4666445A (en) * 1985-10-01 1987-05-19 Tillay Michael J Intraocular lens with shape memory alloy haptic/optic and method of use
US4673406A (en) * 1984-10-29 1987-06-16 Inprohold Establishment One-piece implantation lens
US4676793A (en) * 1984-05-17 1987-06-30 Bechert Ii Charles H Intraocular lens
US4678469A (en) * 1986-10-20 1987-07-07 Kelman Charles D Intraocular lens with glare-inhibiting closure, the method of inhibiting glare, and the closure for same
US4681102A (en) * 1985-09-11 1987-07-21 Bartell Michael T Apparatus and method for insertion of an intra-ocular lens
US4685922A (en) * 1986-06-25 1987-08-11 Peyman Gholam A Alterable refractive power intraocular lenses
US4718906A (en) * 1986-03-11 1988-01-12 Mackool Richard J Intraocular lens
US4720286A (en) * 1984-07-20 1988-01-19 Bailey Kelvin E Multifocus intraocular lens
US4725278A (en) * 1985-01-22 1988-02-16 Shearing Steven P Intraocular lens
US4731079A (en) * 1986-11-26 1988-03-15 Kingston Technologies, Inc. Intraocular lenses
US4731078A (en) * 1985-08-21 1988-03-15 Kingston Technologies Limited Partnership Intraocular lens
US4737558A (en) * 1985-11-25 1988-04-12 Alcon Laboratories, Inc. Siloxane copolymers for ophthalmic applications
US4738680A (en) * 1986-07-03 1988-04-19 Herman Wesley K Laser edge lens
US4753653A (en) * 1986-11-03 1988-06-28 Precision-Cosmet Co., Inc. Foldable bifocal intraocular lens
US4759763A (en) * 1986-11-03 1988-07-26 Precision-Cosmet Co., Inc. Foldable intraocular lens
US4764169A (en) * 1986-12-04 1988-08-16 Grendahl Dennis T Intraocular lens
US4806382A (en) * 1987-04-10 1989-02-21 University Of Florida Ocular implants and methods for their manufacture
US4834754A (en) * 1983-07-08 1989-05-30 Shearing Steven P Intraocular lens
US4840627A (en) * 1986-04-08 1989-06-20 Michael Blumenthal Artificial eye lens and method of transplanting same
US4856234A (en) * 1988-02-26 1989-08-15 Research Machine Center, Inc. Optical lens manufacturing apparatus and method
US4911714A (en) * 1987-03-26 1990-03-27 Poley Brooks J Foldable intraocular lens and improved fold retaining means
US4917680A (en) * 1988-06-30 1990-04-17 Poley Brooks J Folded intraocular lens with endless band retainer
US5041134A (en) * 1989-08-11 1991-08-20 Donnell Francis E O Intraocular lens assembly
FR2666735A1 (en) * 1990-09-13 1992-03-20 Klw Intraocular implant with internal cavity
US5108428A (en) * 1988-03-02 1992-04-28 Minnesota Mining And Manufacturing Company Corneal implants and manufacture and use thereof
US5133751A (en) * 1991-05-20 1992-07-28 Jon Bayers Intraocular lens
US5179262A (en) * 1986-10-14 1993-01-12 Allergan, Inc. Manufacture of ophthalmic lenses by excimer laser
US5180390A (en) * 1991-07-30 1993-01-19 Drews Robert C Intraocular lens with reinforcing element
US5192318A (en) * 1986-06-05 1993-03-09 Schneider Richard T One-piece bifocal intraocular lens construction
US5201763A (en) * 1992-02-28 1993-04-13 Allergan, Inc. Thin intraocular lens
US5203789A (en) * 1991-11-12 1993-04-20 Henry H. McDonald Foldable plastic optical lens with reduced thickness light blocking segments
US5203790A (en) * 1991-11-12 1993-04-20 Henry H. McDonald Foldable plastic optical lens with reduced thickness light blocking segments, and anchoring means
US5236970A (en) * 1987-02-05 1993-08-17 Allergan, Inc. Optically clear reinforced silicone elastomers of high optical refractive index and improved mechanical properties for use in intraocular lenses
US5281294A (en) * 1990-04-17 1994-01-25 Pilkington Diffractive Lenses Limited Manufacture of visual lenses
US5429838A (en) * 1992-10-07 1995-07-04 Pharmacia Ab Method for the production of intraocular lenses
US5593438A (en) * 1995-01-20 1997-01-14 Akhavi; David S. Intraocular lens with metallic coatings for preventing secondary cataracts
US5713958A (en) * 1995-06-22 1998-02-03 W.K. Et Associes Intraocular implant device for correcting ocular anisotropy
US5725811A (en) * 1994-06-27 1998-03-10 Chiron Vision Corporation IOL tumbling process
US5755786A (en) * 1992-09-28 1998-05-26 Iolab Corporation Ophthalmic lens with reduced edge glare
US6010391A (en) * 1996-11-01 2000-01-04 Alcon Laboratories, Inc. Cryogenic polishing method for soft acrylic articles
US6258123B1 (en) * 1995-05-09 2001-07-10 Allergan IOL for reducing secondary opacification
US6264693B1 (en) * 1998-12-11 2001-07-24 Bausch & Lomb Surgical, Inc. Air abrasive texturing process for intraocular implants
US6280471B1 (en) * 1999-09-16 2001-08-28 Gholam A. Peyman Glare-free intraocular lens and method for using the same
US20020028330A1 (en) * 2000-09-06 2002-03-07 Alcon Universal Ltd. Switchable tackiness coating compositions for ophthalmic implants
US20020045938A1 (en) * 1992-02-28 2002-04-18 Brady Daniel G Intraocular lens
US6406739B1 (en) * 2000-01-12 2002-06-18 Alcon Universal Ltd. Coating compositions and methods for reducing edge glare in implantable ophthalmic lenses
US20020095211A1 (en) * 1995-05-09 2002-07-18 Craig Young IOL for reducing secondary opacification
US6425917B1 (en) * 2000-05-12 2002-07-30 Tekia Phakic iol film frame
US6432246B1 (en) * 1988-10-26 2002-08-13 Pharmacia & Upjohn Company Fabrication of an intraocular lens
US6884262B2 (en) * 1998-05-29 2005-04-26 Advanced Medical Optics, Inc. Enhanced intraocular lens for reducing glare
US20050177230A1 (en) * 1996-08-27 2005-08-11 Craig Young IOL for reducing secondary opacification

Family Cites Families (151)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2043840A (en) * 1934-06-23 1936-06-09 Optical Res Corp Ophthalmic lens
US3034403A (en) 1959-04-03 1962-05-15 Neefe Hamilton Res Company Contact lens of apparent variable light absorption
SU142482A1 (en) 1961-04-05 1961-11-30 В.Н. Киселев-Цецхладзе Fish protection device mounted on the suction pipe of the pumping station
US3284406A (en) 1963-12-18 1966-11-08 Dow Corning Organosiloxane encapsulating resins
US3454332A (en) 1966-11-03 1969-07-08 Robert Siegel Corneal plastic contact lens with colored peripheral zone
US3996935A (en) 1969-02-14 1976-12-14 Surgical Design Corporation Surgical-type method for removing material
JPS5135504B2 (en) 1974-01-25 1976-10-02
US3996189A (en) 1975-04-29 1976-12-07 American Optical Corporation Optically clear filled silicone elastomers
US3996187A (en) 1975-04-29 1976-12-07 American Optical Corporation Optically clear filled silicone elastomers
US4172297A (en) 1976-02-24 1979-10-30 Inprohold Establishment Artificial implant lens
US4056855A (en) 1976-04-07 1977-11-08 Charles Kelman Intraocular lens and method of implanting same
US4173798A (en) 1978-05-04 1979-11-13 Welsh Robert C Intra-ocular lens
USRE31626E (en) * 1978-12-01 1984-07-10 Intraocular lens
US4418165A (en) 1980-06-03 1983-11-29 Dow Corning Corporation Optically clear silicone compositions curable to elastomers
US4377873A (en) * 1980-10-30 1983-03-29 Reichert Jr Henry L Intraocular lens
US4370760A (en) * 1981-03-25 1983-02-01 Kelman Charles D Anterior chamber intraocular lens
US5074875A (en) * 1981-10-30 1991-12-24 Anthony Donn Intraocular-external lens combination system and method of using same
US4710197A (en) 1981-10-30 1987-12-01 Anthony Donn Intraocular-external lens combination system and method of using same
US4418431A (en) 1981-12-17 1983-12-06 Feaster Fred T Intraocular lens
US4702244A (en) 1982-02-05 1987-10-27 Staar Surgical Company Surgical device for implantation of a deformable intraocular lens
US4435856A (en) 1982-04-14 1984-03-13 Esperance Francis A L Bifocal intraocular lens structure and spectacle actuation frame
US4412359A (en) * 1982-04-26 1983-11-01 Myers William D Posterior chamber lens implant
US4449257A (en) 1982-05-03 1984-05-22 Barnes-Hind/Hydrocurve, Inc. Intraocular lens and method of retaining in place
GB2124500B (en) 1982-07-22 1986-04-30 Mazzocco Thomas R Improved fixation system for intraocularers structures
US4451938A (en) * 1982-09-24 1984-06-05 Kelman Charles D Intraocular lens and method of positioning the same in an eye
US4454288A (en) 1982-12-02 1984-06-12 Dow Corning Corporation Surface treatment of inorganic fillers
DE3246306A1 (en) * 1982-12-14 1984-06-14 Titmus Eurocon Kontaktlinsen Gmbh & Co Kg, 8750 Aschaffenburg Bifocal lens of bivisual type
US4624670A (en) 1983-04-08 1986-11-25 Bechert Ii Charles H Intraocular lens
US4543398A (en) 1983-04-28 1985-09-24 Minnesota Mining And Manufacturing Company Ophthalmic devices fabricated from urethane acrylates of polysiloxane alcohols
EP0134489A1 (en) 1983-07-20 1985-03-20 McTigue, John Intraocular lens
US4542542A (en) 1983-07-21 1985-09-24 Innovative Surgical Products, Inc. Correction of defects in the eye and compositions therefor
US4585455A (en) * 1983-10-28 1986-04-29 Ioptex Inc. Intraocular lens with iris spacer mechanism
JPS60163901A (en) 1984-02-04 1985-08-26 Japan Synthetic Rubber Co Ltd Plasma polymerization treatment
US4605409A (en) 1984-05-21 1986-08-12 Kelman Charles D Intraocular lens with miniature optic having expandable and contractible glare-reducing means
US4629460A (en) 1984-06-25 1986-12-16 Dyer Robert L Intraocular lens
NL8500527A (en) 1984-06-25 1986-01-16 Aziz Yehia Anis FLEXIBLE LENS FOR THE REAR EYE CHAMBER.
US4576607A (en) * 1984-07-13 1986-03-18 Kelman Charles D Intraocular lenses
ATE57606T1 (en) 1984-09-07 1990-11-15 Richard H Keates FLEXIBLE INTRAOCULAR LENS HOLDER.
US4615702A (en) 1984-09-10 1986-10-07 Koziol Jeffrey E Intraocular lens and method of forming the lens
US4601722A (en) 1984-10-30 1986-07-22 Kelman Charles D Intraocular lens
EP0186634B1 (en) 1984-12-03 1991-07-03 Precision-Cosmet Co., Inc. Intraocular lens with foldable sides
US4704124A (en) 1985-01-22 1987-11-03 Shearing Steven P Intraocular lens
US4743254A (en) 1985-01-31 1988-05-10 American Hospital Supply Company Small incision intraocular lens
GB2171912A (en) 1985-03-05 1986-09-10 Charles William Simcoe Hinged intraocular lens
EP0195881A1 (en) 1985-03-27 1986-10-01 Pharmacia Ab Intraocular lens
US4619662A (en) 1985-04-19 1986-10-28 Juergens Jr Albert M Intraocular lens
US4704122A (en) 1985-04-30 1987-11-03 American Hospital Supply Corp. Bi-concave small incision intraocular lens
CA1273144A (en) 1985-05-07 1990-08-21 Takafumi Uemiya Cross-linked optical siloxane polymer
US4781717A (en) 1985-07-24 1988-11-01 Grendahl Dennis T Intraocular lens
US4676791A (en) 1985-08-01 1987-06-30 Surgidev Corporation Intraocular lens and method for making same
DE3532928A1 (en) 1985-09-14 1987-04-02 Fromberg Gunter ARTIFICIAL LENS FOR IMPLANTATION IN THE EYE
US4715373A (en) 1985-09-27 1987-12-29 Mazzocco Thomas R Devices for implantation of deformable intraocular lens structures
IT1197356B (en) 1985-10-15 1988-11-30 Storz Instr Co INTRAOCULAR LENSES WITH ANTI-GLARE EDGES
SE8505518D0 (en) 1985-11-22 1985-11-22 Swedish Graft Tech Ab IMPLANTATION LENS, PROCEDURE FOR PREPARING THEREOF AND APPARATUS FOR CARRYING OUT THE PROCEDURE
US4834751A (en) 1985-12-04 1989-05-30 Allergan, Inc. Staking ring for soft IOL
US4790846A (en) 1985-12-09 1988-12-13 Allergan Pharmaceuticals, Inc. Haptic to optic attachment for a soft IOL
DE3610833A1 (en) 1986-04-01 1987-10-08 Inprohold Ets INTRAOCULAR IMPLANTATION LENS
US4755182A (en) 1986-04-14 1988-07-05 Iolab Corporation Reduced glare intraocular lens
US4710195A (en) 1986-04-18 1987-12-01 Giovinazzo Vincent J Posterior chamber intraocular lens
EP0246754A1 (en) 1986-04-21 1987-11-25 Kelman, Charles D. Intraocular lens having glare-inhibiting means
US4711638A (en) 1986-05-12 1987-12-08 Lindstrom Richard L Intraocular lens
JPS634990A (en) 1986-06-25 1988-01-09 Jujo Paper Co Ltd Thermal recording material
US4704123A (en) 1986-07-02 1987-11-03 Iolab Corporation Soft intraocular lens
US5053171A (en) 1986-10-14 1991-10-01 Allergan, Inc. Manufacture of ophthalmic lenses by excimer laser
US5061840A (en) 1986-10-14 1991-10-29 Allergan, Inc. Manufacture of ophthalmic lenses by excimer laser
US4842782A (en) 1986-10-14 1989-06-27 Allergan, Inc. Manufacture of ophthalmic lenses by excimer laser
US4710194A (en) 1986-10-20 1987-12-01 Kelman Charles D Intraocular lens with optic of expandable hydrophilic material
EP0268569B1 (en) 1986-11-03 1991-03-20 Precision-Cosmet Co., Inc. Foldable intraocular lens
US4868251A (en) 1986-12-24 1989-09-19 Allergan, Inc. Ultraviolet light absorbing silicone compositions
US4863465A (en) 1987-02-10 1989-09-05 Kelman Charles D Intraocular lens with multiple-fulcrum haptic
US4769034A (en) 1987-03-26 1988-09-06 Poley Brooks J Folded intraocular lens, method of implanting folded intraocular lens
US4769035A (en) 1987-06-02 1988-09-06 Kelman Charles D Artificial lens and the method for implanting such lens
SU1537244A1 (en) 1987-07-14 1990-01-23 Всесоюзный Научно-Исследовательский Институт Глазных Болезней Artificial eye lens
US4785047A (en) 1987-07-30 1988-11-15 Dow Corning Corporation Method for preparing clear polyorganosiloxane elastomers
US4808181A (en) 1987-08-07 1989-02-28 Kelman Charles D Intraocular lens having roughened surface area
US5147394A (en) 1987-10-09 1992-09-15 Siepser Steven B High refractive index polymeric compositions suitable for use as expansile hydrogel intraocular lenses
US4781718A (en) 1987-10-09 1988-11-01 Lindstrom Richard L Intraocular lens
US5054905A (en) 1987-11-12 1991-10-08 Cohen Allen L Progressive intensity phase bifocal
US5074876A (en) 1987-12-04 1991-12-24 Kelman Charles D Two piece intraocular lens
US4863464A (en) 1988-01-26 1989-09-05 The Cooper Companies, Inc. Intraocular lens
JPH0761357B2 (en) 1988-03-28 1995-07-05 ホーヤ株式会社 Intraocular lens
US5076684A (en) 1988-04-01 1991-12-31 Minnesota Mining And Manufacturing Company Multi-focal diffractive ophthalmic lenses
SE468199B (en) 1988-04-11 1992-11-23 Astra Ab KNAELEDSPROTES
CS271606B1 (en) 1988-04-11 1990-10-12 Sulc Jiri Intraocular optical system
WO1989009576A1 (en) 1988-04-15 1989-10-19 Schneider Richard T One-piece bifocal intraocular lens construction
US4878910A (en) 1988-06-13 1989-11-07 Koziol Jeffrey E Intraocular lens assembly
DE3827072A1 (en) 1988-08-10 1990-02-15 Gunter Dr Fromberg ARTIFICIAL EYE LENS
US4882398A (en) 1988-08-26 1989-11-21 Dow Corning Corporation Optically clear reinforced organosiloxane compositions
US5011494A (en) * 1988-09-16 1991-04-30 Clemson University Soft tissue implant with micron-scale surface texture to optimize anchorage
US4878912A (en) 1988-11-09 1989-11-07 Castleman Lawrence D Foldable intraocular disc lens
US4990159A (en) * 1988-12-02 1991-02-05 Kraff Manus C Intraocular lens apparatus with haptics of varying cross-sectional areas
US5002571A (en) 1989-02-06 1991-03-26 Donnell Jr Francis E O Intraocular lens implant and method of locating and adhering within the posterior chamber
US4978352A (en) 1989-06-07 1990-12-18 Fedorov Svjatoslav N Process for producing collagen-based cross-linked biopolymer, an implant from said biopolymer, method for producing said implant, and method for hermetization of corneal or scleral wounds involved in eye injuries, using said implant
CA2019201A1 (en) 1989-06-19 1990-12-19 John D. Hunkeler Single piece ovoid intraocular lens with haptic
JP2840298B2 (en) 1989-06-22 1998-12-24 株式会社メニコン Intraocular lens
EP0419740A1 (en) 1989-09-27 1991-04-03 HANITA LENSES (a Limited Partnership) Negative-power intraocular lens
FR2655842B1 (en) 1989-12-20 1993-09-17 Maigret Yves EYE IMPLANT WITH GRADIENT OF VARIABLE INDEX AND MANUFACTURING METHOD THEREOF.
US5089023A (en) 1990-03-22 1992-02-18 Massachusetts Institute Of Technology Diffractive/refractive lens implant
US5078740A (en) * 1990-04-02 1992-01-07 Walman Gerald B Intraocular lens
FR2661816A1 (en) 1990-05-14 1991-11-15 Arneodo Jacques Artificial crystalline lens comprising means promoting implantation in order to ensure imperviousness and prevent the migration of the aqueous humor towards the rear
US5096285A (en) 1990-05-14 1992-03-17 Iolab Corporation Multifocal multizone diffractive ophthalmic lenses
US5178636A (en) 1990-05-14 1993-01-12 Iolab Corporation Tuned fresnel lens for multifocal intraocular applications including small incision surgeries
GB9011424D0 (en) 1990-05-22 1990-07-11 Bicc Plc Multi-part optical fibre connectors
FR2666220B1 (en) * 1990-09-04 1996-03-01 Domilens Lab INTRAOCULAR IMPLANT FOR CORRECTION OF MYOPIA.
FR2668922A1 (en) 1990-11-14 1992-05-15 Franceschi Francois CRYSTALLINE IMPLANT OF POSTERIOR CHAMBER.
JP2540879Y2 (en) 1990-11-30 1997-07-09 株式会社メニコン Intraocular lens
US5217491A (en) * 1990-12-27 1993-06-08 American Cyanamid Company Composite intraocular lens
WO1992014421A1 (en) 1991-02-21 1992-09-03 Grendahl Dennis T Halo-reducing ophthalmic lens for small incision implant surgery
WO1992015260A1 (en) 1991-03-01 1992-09-17 Arnott Eric J Intraocular lens with tapered holding loops
EP0507292B1 (en) 1991-04-04 1997-07-02 Menicon Co., Ltd. Device for inhibiting aftercataract
FR2675038B3 (en) * 1991-04-10 1993-07-16 France Chirurgie Instrumentation MESOPROSTHESIS SUPPORT.
EP0514096A3 (en) 1991-05-13 1993-03-31 Ioptex Research Inc. Deformable-elastic intraocular lens
US5133749A (en) 1991-05-13 1992-07-28 Nordan Lee T Centrating haptics
AU667816B2 (en) 1991-06-24 1996-04-18 Gillette Company, The Improvements in or relating to razor blades
US5147395A (en) 1991-07-16 1992-09-15 Allergan Inc. Small incision endocapsulator IOL
EP0567627A4 (en) 1991-11-14 1994-06-22 Stanley Poler Secondary eye growth impeding device and method
US5266241A (en) 1992-02-12 1993-11-30 Iolab Corporation Haptic attachment for soft intraocular lens
US5476513A (en) 1992-02-28 1995-12-19 Allergan, Inc. Intraocular lens
US5405385A (en) 1992-04-02 1995-04-11 Clemson University Intraocular lens with integrated means of fixation
FR2689755B1 (en) 1992-04-14 1999-08-06 Corneal INTRAOCULAR IMPLANT FOR CAPSULAR BAG.
US5197981A (en) * 1992-04-23 1993-03-30 Alcon Surgical, Inc. Intraocular lens having haptic of specific curvature and proportion
FR2693649B1 (en) 1992-07-16 1994-10-14 Corneal Flexible intraocular implant.
ATE180159T1 (en) 1992-09-28 1999-06-15 Iolab Corp ARTIFICIAL EYE LENS WITH REDUCED EDGE GLARE
US5331073A (en) 1992-11-09 1994-07-19 Allergan, Inc. Polymeric compositions and intraocular lenses made from same
JP2805719B2 (en) 1993-01-29 1998-09-30 ホーヤ株式会社 One-piece intraocular lens
US5366501A (en) 1993-05-12 1994-11-22 Langerman David W Intraocular lens with dual 360 degree haptics
US5405386A (en) * 1993-07-09 1995-04-11 Kabi Pharmacia Ophthalmics, Inc. Intraocular lens with improved cylindrical haptic
JP3379717B2 (en) 1993-07-15 2003-02-24 キヤノンスター株式会社 Deformable intraocular lens
US5376115A (en) 1993-08-02 1994-12-27 Pharmacia Ab Intraocular lens with vaulting haptic
DE69435264D1 (en) 1993-08-27 2010-02-25 Nice Trust St Martin Accommodatable intraocular lens
HRP931478A2 (en) 1993-12-06 1995-12-31 Ferek Petri Bo Idar An apparatus for cardial electrotherapy containing transmission line uring cardial contractions
CA2142558C (en) 1994-02-17 2001-10-16 George J. Woffinden Ophthalmic lens with reduced edge glare
CZ282355B6 (en) 1994-12-01 1997-07-16 Vladimír Ing. Csc. Stoy Implantable ophthalmic lens, process of its production and a mould for making the same
JP2967093B2 (en) 1995-02-23 1999-10-25 ホーヤ株式会社 Flexible intraocular lens
US5549670A (en) 1995-05-09 1996-08-27 Allergan, Inc. IOL for reducing secondary opacification
JP3429392B2 (en) 1995-05-24 2003-07-22 Hoya株式会社 Flexible intraocular lens
US5716403A (en) * 1995-12-06 1998-02-10 Alcon Laboratories, Inc. Single piece foldable intraocular lens
FR2746000B1 (en) * 1996-03-14 1998-06-12 FLEXIBLE INTRAOCULAR IMPLANT AND SET OF SUCH IMPLANTS
JPH10211A (en) 1996-06-18 1998-01-06 Okifumi Nishi Intraocular lens
WO1998016161A1 (en) 1996-10-11 1998-04-23 Transvascular, Inc. Methods and apparatus for bypassing arterial obstructions and/or performing other transvascular procedures
US5961370A (en) 1997-05-08 1999-10-05 Chiron Vision Corporation Intraocular lens tumbling process using coated beads
US6027531A (en) * 1997-10-14 2000-02-22 Tassignon; Marie-Joseb. R. Intraocular lens and method for preventing secondary opacification
JP3569617B2 (en) 1997-11-13 2004-09-22 本田技研工業株式会社 Switch mounting structure for vehicle
US6129759A (en) 1997-12-10 2000-10-10 Staar Surgical Company, Inc. Frosted haptic intraocular lens
US6162249A (en) 1998-05-29 2000-12-19 Allergan IOI for inhibiting cell growth and reducing glare
US6468306B1 (en) 1998-05-29 2002-10-22 Advanced Medical Optics, Inc IOL for inhibiting cell growth and reducing glare
US6190410B1 (en) 1999-04-29 2001-02-20 Bausch & Lomb Surgical, Inc. Intraocular lenses
JP4909469B2 (en) 2001-06-25 2012-04-04 株式会社メニコン Ophthalmic lens and manufacturing method thereof
IL145015A0 (en) 2001-08-21 2002-06-30 Nun Yehoshua Ben Accommodating lens
US6648741B2 (en) 2002-03-14 2003-11-18 Advanced Medical Optics, Inc. Apparatus for protecting the edge geometry of an intraocular lens during glass bead polishing process
EP1595881A1 (en) 2004-05-12 2005-11-16 Pfizer Limited Tetrahydronaphthyridine derivates useful as histamine H3 receptor ligands

Patent Citations (100)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2110724A (en) * 1936-08-20 1938-03-08 Goettel Peter Waxing device
US3341490A (en) * 1964-08-13 1967-09-12 Dow Corning Blends of two polysiloxane copolymers with silica
US3457214A (en) * 1965-12-15 1969-07-22 Gen Electric Low temperature vulcanizing composition and article made therefrom
US3578850A (en) * 1970-02-11 1971-05-18 Alan H Grant Anti-flare contact lens
US4092743A (en) * 1976-10-04 1978-06-06 Kelman Charles D Intraocular lenses
US4168547A (en) * 1977-04-01 1979-09-25 Medicinska Akademia Anterior-chamber lens-carrier
US4189546A (en) * 1977-07-25 1980-02-19 Bausch & Lomb Incorporated Polysiloxane shaped article for use in biomedical applications
US4435050A (en) * 1980-02-26 1984-03-06 Stanley Poler Contact lens assembly with haptic and method for making the same
US4571040A (en) * 1980-02-26 1986-02-18 Lynell Medical Technology, Inc. Contact lens and haptic
US4521273A (en) * 1980-02-26 1985-06-04 Stanley Poler Method of making a lens and haptic assembly
US4439873A (en) * 1980-02-26 1984-04-03 Stanley Poler Intra-ocular lens construction
US4424597A (en) * 1981-05-13 1984-01-10 Inprohold Establishment Posterior chamber implant lens
US4402579A (en) * 1981-07-29 1983-09-06 Lynell Medical Technology Inc. Contact-lens construction
US4380643A (en) * 1981-08-24 1983-04-19 Asahi Glass Company, Ltd. Benzotriazole compound and homopolymer or copolymers thereof
US4525346A (en) * 1981-09-28 1985-06-25 Alcon Laboratories, Inc. Aqueous antimicrobial ophthalmic solutions
US4450593A (en) * 1981-11-09 1984-05-29 Lynell Medical Technology Inc. Intraocular and contact lens construction
US4440918A (en) * 1982-01-18 1984-04-03 Minnesota Mining And Manufacturing Company Contact lens containing a fluorinated telechelic polyether
US4429421A (en) * 1982-02-03 1984-02-07 Levy Chauncey F Method of implanting an intraocular lens
US4423809A (en) * 1982-02-05 1984-01-03 Staar Surgical Company, Inc. Packaging system for intraocular lens structures
US4573998A (en) * 1982-02-05 1986-03-04 Staar Surgical Co. Methods for implantation of deformable intraocular lenses
US4470159A (en) * 1982-03-03 1984-09-11 Peyman Gholam A Keratoprosthesis
US4435866A (en) * 1982-03-04 1984-03-13 Royden Brown Pollen trap for beehives with dual entranceways
US4494254A (en) * 1982-05-03 1985-01-22 Osvaldo Lopez Intraocular lens
US4468820A (en) * 1982-05-10 1984-09-04 Precision-Cosmet Co., Inc. Haptic attachment for intraocular lenses
US4449267A (en) * 1982-05-26 1984-05-22 Siemion Edward D Floor seal strip
US4664667A (en) * 1982-06-28 1987-05-12 Kelman Charles D Deformable intraocular lens
US4608049A (en) * 1982-06-28 1986-08-26 Kelman Charles D Intraocular lens and method of inserting an intraocular lens into an eye
US4535488A (en) * 1982-09-30 1985-08-20 Haddad Heskel M Anterior-posterior chamber intraocular lens
US4652622A (en) * 1983-04-29 1987-03-24 Bausch & Lomb Incorporated Polysiloxane composition with improved surface wetting characteristics and biomedical devices made thereof
US4495361A (en) * 1983-04-29 1985-01-22 Bausch & Lomb Incorporated Polysiloxane composition with improved surface wetting characteristics and biomedical devices made thereof
US4657546A (en) * 1983-07-08 1987-04-14 Shearing Steven P Intraocular lens
US4834754A (en) * 1983-07-08 1989-05-30 Shearing Steven P Intraocular lens
US4537943A (en) * 1983-07-21 1985-08-27 Innovative Surgical Products, Inc. Correction of defects in the eye and compositions therefor
US4608050A (en) * 1983-07-21 1986-08-26 Innovative Surgical Products, Inc. Correction of defects in the eye and compositions therefor
US4580371A (en) * 1983-10-17 1986-04-08 Iolab Corporation Method for tumble grinding optical lens edge
US4541206A (en) * 1983-10-17 1985-09-17 Iolab Corp. Fixture for holding an optical lens during tumbling
US4562600A (en) * 1983-10-18 1986-01-07 Stephen P. Ginsberg Intraocular lens
US4597388A (en) * 1983-12-15 1986-07-01 Trutek Research, Inc. Apparatus for removing cataracts
US4570626A (en) * 1984-01-20 1986-02-18 Norris John L Corneal light shield
US4532267A (en) * 1984-02-15 1985-07-30 Board Of Regents, University Of Washington Vision correction lens made from an aminopolysaccharide compound or an ether or ester thereof
US4535141A (en) * 1984-03-23 1985-08-13 Dow Corning Corporation Liquid curable polyorganosiloxane compositions
US4601545A (en) * 1984-05-16 1986-07-22 Kern Seymour P Variable power lens system
US4676793A (en) * 1984-05-17 1987-06-30 Bechert Ii Charles H Intraocular lens
US4720286A (en) * 1984-07-20 1988-01-19 Bailey Kelvin E Multifocus intraocular lens
US4673406A (en) * 1984-10-29 1987-06-16 Inprohold Establishment One-piece implantation lens
US4575373A (en) * 1984-11-02 1986-03-11 Johnson Don R Laser adjustable intraocular lens and method of altering lens power
US4725278A (en) * 1985-01-22 1988-02-16 Shearing Steven P Intraocular lens
US4585457A (en) * 1985-05-16 1986-04-29 Kalb Irvin M Inflatable intraocular lens
US4661108A (en) * 1985-07-03 1987-04-28 Surgidev Corporation Intraocular lens
US4588406A (en) * 1985-08-15 1986-05-13 Fedorov Svjatoslav N Intraocular lens
US4731078A (en) * 1985-08-21 1988-03-15 Kingston Technologies Limited Partnership Intraocular lens
US4647282A (en) * 1985-08-27 1987-03-03 Moskovsky Nauchno-Issledovatelsky Institut Mikrokhirurgii Glaza Material for ocular prosthetics
US4681102A (en) * 1985-09-11 1987-07-21 Bartell Michael T Apparatus and method for insertion of an intra-ocular lens
US4666445A (en) * 1985-10-01 1987-05-19 Tillay Michael J Intraocular lens with shape memory alloy haptic/optic and method of use
US4737558A (en) * 1985-11-25 1988-04-12 Alcon Laboratories, Inc. Siloxane copolymers for ophthalmic applications
US4636210A (en) * 1985-12-09 1987-01-13 Hoffer Kenneth J Multi-part intraocular lens and method of implanting it in an eye
US4718906A (en) * 1986-03-11 1988-01-12 Mackool Richard J Intraocular lens
US4840627A (en) * 1986-04-08 1989-06-20 Michael Blumenthal Artificial eye lens and method of transplanting same
US5192318A (en) * 1986-06-05 1993-03-09 Schneider Richard T One-piece bifocal intraocular lens construction
US4685922A (en) * 1986-06-25 1987-08-11 Peyman Gholam A Alterable refractive power intraocular lenses
US4738680A (en) * 1986-07-03 1988-04-19 Herman Wesley K Laser edge lens
US5179262A (en) * 1986-10-14 1993-01-12 Allergan, Inc. Manufacture of ophthalmic lenses by excimer laser
US4678469A (en) * 1986-10-20 1987-07-07 Kelman Charles D Intraocular lens with glare-inhibiting closure, the method of inhibiting glare, and the closure for same
US4753653A (en) * 1986-11-03 1988-06-28 Precision-Cosmet Co., Inc. Foldable bifocal intraocular lens
US4759763A (en) * 1986-11-03 1988-07-26 Precision-Cosmet Co., Inc. Foldable intraocular lens
US4731079A (en) * 1986-11-26 1988-03-15 Kingston Technologies, Inc. Intraocular lenses
US4764169A (en) * 1986-12-04 1988-08-16 Grendahl Dennis T Intraocular lens
US5494946A (en) * 1987-02-05 1996-02-27 Allergan, Inc. Optically clear reinforced silicone elastomers of high optical refractive index and improved mechanical properties for use in intraocular lenses
US5236970A (en) * 1987-02-05 1993-08-17 Allergan, Inc. Optically clear reinforced silicone elastomers of high optical refractive index and improved mechanical properties for use in intraocular lenses
US4911714A (en) * 1987-03-26 1990-03-27 Poley Brooks J Foldable intraocular lens and improved fold retaining means
US4806382A (en) * 1987-04-10 1989-02-21 University Of Florida Ocular implants and methods for their manufacture
US4856234A (en) * 1988-02-26 1989-08-15 Research Machine Center, Inc. Optical lens manufacturing apparatus and method
US5108428A (en) * 1988-03-02 1992-04-28 Minnesota Mining And Manufacturing Company Corneal implants and manufacture and use thereof
US4917680A (en) * 1988-06-30 1990-04-17 Poley Brooks J Folded intraocular lens with endless band retainer
US6432246B1 (en) * 1988-10-26 2002-08-13 Pharmacia & Upjohn Company Fabrication of an intraocular lens
US5041134A (en) * 1989-08-11 1991-08-20 Donnell Francis E O Intraocular lens assembly
US5281294A (en) * 1990-04-17 1994-01-25 Pilkington Diffractive Lenses Limited Manufacture of visual lenses
FR2666735A1 (en) * 1990-09-13 1992-03-20 Klw Intraocular implant with internal cavity
US5133751A (en) * 1991-05-20 1992-07-28 Jon Bayers Intraocular lens
US5180390A (en) * 1991-07-30 1993-01-19 Drews Robert C Intraocular lens with reinforcing element
US5203790A (en) * 1991-11-12 1993-04-20 Henry H. McDonald Foldable plastic optical lens with reduced thickness light blocking segments, and anchoring means
US5203789A (en) * 1991-11-12 1993-04-20 Henry H. McDonald Foldable plastic optical lens with reduced thickness light blocking segments
US20020045938A1 (en) * 1992-02-28 2002-04-18 Brady Daniel G Intraocular lens
US6692525B2 (en) * 1992-02-28 2004-02-17 Advanced Medical Optics, Inc. Intraocular lens
US5201763A (en) * 1992-02-28 1993-04-13 Allergan, Inc. Thin intraocular lens
US5755786A (en) * 1992-09-28 1998-05-26 Iolab Corporation Ophthalmic lens with reduced edge glare
US5429838A (en) * 1992-10-07 1995-07-04 Pharmacia Ab Method for the production of intraocular lenses
US5725811A (en) * 1994-06-27 1998-03-10 Chiron Vision Corporation IOL tumbling process
US5593438A (en) * 1995-01-20 1997-01-14 Akhavi; David S. Intraocular lens with metallic coatings for preventing secondary cataracts
US6258123B1 (en) * 1995-05-09 2001-07-10 Allergan IOL for reducing secondary opacification
US20020095211A1 (en) * 1995-05-09 2002-07-18 Craig Young IOL for reducing secondary opacification
US5713958A (en) * 1995-06-22 1998-02-03 W.K. Et Associes Intraocular implant device for correcting ocular anisotropy
US20050177230A1 (en) * 1996-08-27 2005-08-11 Craig Young IOL for reducing secondary opacification
US6010391A (en) * 1996-11-01 2000-01-04 Alcon Laboratories, Inc. Cryogenic polishing method for soft acrylic articles
US6884262B2 (en) * 1998-05-29 2005-04-26 Advanced Medical Optics, Inc. Enhanced intraocular lens for reducing glare
US6264693B1 (en) * 1998-12-11 2001-07-24 Bausch & Lomb Surgical, Inc. Air abrasive texturing process for intraocular implants
US6280471B1 (en) * 1999-09-16 2001-08-28 Gholam A. Peyman Glare-free intraocular lens and method for using the same
US6406739B1 (en) * 2000-01-12 2002-06-18 Alcon Universal Ltd. Coating compositions and methods for reducing edge glare in implantable ophthalmic lenses
US6425917B1 (en) * 2000-05-12 2002-07-30 Tekia Phakic iol film frame
US20020028330A1 (en) * 2000-09-06 2002-03-07 Alcon Universal Ltd. Switchable tackiness coating compositions for ophthalmic implants

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
machine generated English translation of FR 2 666 735 A1 (published on March 20, 1992). *

Also Published As

Publication number Publication date
US20030114926A1 (en) 2003-06-19
US20030055498A1 (en) 2003-03-20
US7252683B2 (en) 2007-08-07
US20030130733A1 (en) 2003-07-10
US9949822B2 (en) 2018-04-24
US20140163674A1 (en) 2014-06-12
US6468306B1 (en) 2002-10-22
US20030060879A1 (en) 2003-03-27

Similar Documents

Publication Publication Date Title
US9949822B2 (en) Intraocular lens for inhibiting cell growth and reducing glare
US6884262B2 (en) Enhanced intraocular lens for reducing glare
EP1246586B1 (en) Iol for inhibiting cell growth and reducing glare
US6162249A (en) IOI for inhibiting cell growth and reducing glare
EP2152202B1 (en) Iol peripheral surface designs to reduce negative dysphotopsia
US6656222B2 (en) IOL for reducing secondary opacification
US20080269885A1 (en) IOL Peripheral Surface Designs to Reduce Negative Dysphotopsia
US20080269890A1 (en) Intraocular lens with peripheral region designed to reduce negative dysphotopsia
US20030195621A1 (en) IOL for reducing secondary opacification
US20080269882A1 (en) Intraocular lens with asymmetric optics
US20070106379A1 (en) Intraocular lens
US20080015690A1 (en) IOL For Reducing Secondary Opacification
AU2003271372B2 (en) IOL for inhibiting cell growth and reducing glare
US20020173845A1 (en) Low surface-glare intraocular lenses

Legal Events

Date Code Title Description
AS Assignment

Owner name: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT,NOR

Free format text: INTELLECTUAL PROPERTY SECURITY AGREEMENT;ASSIGNOR:ADVANCED MEDICAL OPTICS, INC.;REEL/FRAME:019501/0069

Effective date: 20070402

Owner name: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT, NORTH CAROLINA

Free format text: INTELLECTUAL PROPERTY SECURITY AGREEMENT;ASSIGNOR:ADVANCED MEDICAL OPTICS, INC.;REEL/FRAME:019501/0069

Effective date: 20070402

Owner name: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT, NO

Free format text: INTELLECTUAL PROPERTY SECURITY AGREEMENT;ASSIGNOR:ADVANCED MEDICAL OPTICS, INC.;REEL/FRAME:019501/0069

Effective date: 20070402

AS Assignment

Owner name: ADVANCED MEDICAL OPTICS, INC., CALIFORNIA

Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:BANK OF AMERICA, N.A. AS ADMINISTRATIVE AGENT;REEL/FRAME:022320/0427

Effective date: 20090225

Owner name: ADVANCED MEDICAL OPTICS, INC.,CALIFORNIA

Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:BANK OF AMERICA, N.A. AS ADMINISTRATIVE AGENT;REEL/FRAME:022320/0427

Effective date: 20090225

AS Assignment

Owner name: ABBOTT MEDICAL OPTICS INC., CALIFORNIA

Free format text: MERGER;ASSIGNOR:ADVANCED MEDICAL OPTICS, INC.;REEL/FRAME:023234/0277

Effective date: 20090226

Owner name: ABBOTT MEDICAL OPTICS INC.,CALIFORNIA

Free format text: MERGER;ASSIGNOR:ADVANCED MEDICAL OPTICS, INC.;REEL/FRAME:023234/0277

Effective date: 20090226

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION